Chiralix rac-GR24 独脚金内酯

金山科研平台代理微信：jinshanbiorac-GR24是一类的植物激素。独脚金内酯（strigolactones）从植物的根中释放，可诱导根寄生杂草如独脚金属（Strigaspp.）、列当属（Orobanchespp.）的种子萌发，及丛枝菌根（Arbuscular mycorrhiza，AM）真菌菌丝（hyphae）分枝。rac-GR24是独脚金内酯的人工合成类似物，于2008年由英国的科研人员确认为植物第7大类植物激素。

上海起福生物科技rac-GR24现货供应，价格特惠。

Chiralix rac-GR24 独脚金内酯（Strigolactones）现货

rac-GR24
A potent synthetic strigolactone analog.
Chemical Name	（3aR*,8bS*,E）-3-（（（R*）-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy）methylene）-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one
CAS Number	[76974-79-3]
Structure
Molecular Formula	C17H14O5
Molecular Weight	298.29
Purity	>98%

Chiralix rac-GR24 独脚金内酯（Strigolactones）现货

rac-GR24目前发现有以下作用：

作为环境刺激型号，可以诱发杂草种子萌发，例如：列当等寄生性杂草。

作为化感物质，可以促进菌根生长，与植物更好的协调物质运输与分配。此外，有人发现根瘤菌固氮效率可能与Strigolactones也有一定的关系。

作为激素：在控制植物分支和激素协调作用方面，有着重要的作用。目前的研究主要集中在这方面。另外，发现Strigolactones与植物抗逆重要的信号物质ABA在通路上有交叉，并且与生理上经典的ABC模型在激素的运输上也有关系，所以Strigolactones很可能是植物激素调控网络中重要的节点物质。

总之, Strigolactones在杂草控制，杂草检验检疫，植株塑性，作物栽培，品种选育以及基础科研方面都有着重要的应用价值和科研价

产品订购信息如下：

Order No.	Quantity	Price
CX23880-5MG	5 milligrams	6000
CX23880-20MG	20 milligrams	17000
CX23880-100MG	100 milligrams	39000 g

公司其他产品

货号	品名	化学名	CAS号	分子量	分子式	Synonyms	纯度	包装	价格	品牌
CX90418-1G	L-allysineethyleneacetal	(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid	215054-80-1	189.21	C8H15NO4	H-Aea-OH	99%	1G	6200	chiralix
CX90418-2G	L-allysineethyleneacetal	(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid	215054-80-1	189.21	C8H15NO4	H-Aea-OH	99%	2G	10600	chiralix
CX90418-5G	L-allysineethyleneacetal	(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid	215054-80-1	189.21	C8H15NO4	H-Aea-OH	99%	5G	19900	chiralix
CX60325-200MG	D-homopropargylglycine	(R)-2-aminohex-5-ynoicacid	211054-02-3	127.14	C6H9NO2	H-D-Hpg-OH	>98%	200MG	4800	chiralix
CX60325-500MG	D-homopropargylglycine	(R)-2-aminohex-5-ynoicacid	211054-02-3	127.14	C6H9NO2	H-D-Hpg-OH	>98%	500MG	9800	chiralix
CX60325-1G	D-homopropargylglycine	(R)-2-aminohex-5-ynoicacid	211054-02-3	127.14	C6H9NO2	H-D-Hpg-OH	>98%	1G	16000	chiralix
CX80065-500MG	Fmoc-L-homopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	942518-21-0	349.38	C21H19NO4	Fmoc-Hpg-OH	>97%	500MG	11200	chiralix
CX80065-1G	Fmoc-L-homopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	942518-21-0	349.38	C21H19NO4	Fmoc-Hpg-OH	>97%	1G	18400	chiralix
CX90138-200MG	L-homopropargylglycine	(S)-2-aminohex-5-ynoicacid	98891-36-2	127.14	C6H9NO2	H-Hpg-OH	>98%	200MG	4800	chiralix
CX90138-500MG	L-homopropargylglycine	(S)-2-aminohex-5-ynoicacid	98891-36-2	127.14	C6H9NO2	H-Hpg-OH	>98%	500MG	9800	chiralix
CX90138-1G	L-homopropargylglycine	(S)-2-aminohex-5-ynoicacid	98891-36-2	127.14	C6H9NO2	H-Hpg-OH	>98%	1G	16000	chiralix
CX56292-500MG	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	108646-25-9	156.14	C7H8O4		>97%	500MG	6000	chiralix
CX56292-1G	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	108646-25-9	156.14	C7H8O4		>97%	1G	9800	chiralix
CX24022-500MG	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	38127-17-2	155.15	C7H9NO3		>98%	500MG	6000	chiralix
CX24022-1G	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	38127-17-2	155.15	C7H9NO3		>98%	1G	9800	chiralix
CX41399-1G	(S)-beta3-phenylalanine	(S)-3-amino-3-phenylpropanoicacid	40856-44-8	165.19	C9H11NO2		99%	1G	2200	chiralix
CX41399-2G	(S)-beta3-phenylalanine	(S)-3-amino-3-phenylpropanoicacid	40856-44-8	165.19	C9H11NO2		99%	2G	3800	chiralix
CX41399-5G	(S)-beta3-phenylalanine	(S)-3-amino-3-phenylpropanoicacid	40856-44-8	165.19	C9H11NO2		99%	5G	7200	chiralix
CX64691-1G	D-tert-leucine	(R)-2-amino-3,3-dimethylbutyricacid	26782-71-8	131.17	C6H13NO2	H-D-tert-Leu-OH	99%	1G	2200	chiralix
CX64691-2G	D-tert-leucine	(R)-2-amino-3,3-dimethylbutyricacid	26782-71-8	131.17	C6H13NO2	H-D-tert-Leu-OH	99%	2G	3800	chiralix
CX64691-5G	D-tert-leucine	(R)-2-amino-3,3-dimethylbutyricacid	26782-71-8	131.17	C6H13NO2	H-D-tert-Leu-OH	99%	5G	7200	chiralix
CX97471-500MG	(S)-alpha-methyl-phenylglycine	(S)-2-amino-2-phenylpropanoicacid	13398-26-0	165.19	C9H11NO2	(S)-H-Mpg-OH	>98%	500MG	5200	chiralix
CX97471-1G	(S)-alpha-methyl-phenylglycine	(S)-2-amino-2-phenylpropanoicacid	13398-26-0	165.19	C9H11NO2	(S)-H-Mpg-OH	>98%	1G	9000	chiralix
CX97471-2G	(S)-alpha-methyl-phenylglycine	(S)-2-amino-2-phenylpropanoicacid	13398-26-0	165.19	C9H11NO2	(S)-H-Mpg-OH	>98%	2G	14800	chiralix
CX58692-1G	(S)-allylglycinolhydrochloride	(S)-2-aminopent-4-en-1-olhydrochloride	926660-03-9	137.61	C5H12ClNO		>98%	1G	7400	chiralix
CX58692-2G	(S)-allylglycinolhydrochloride	(S)-2-aminopent-4-en-1-olhydrochloride	926660-03-9	137.61	C5H12ClNO		>98%	2G	12800	chiralix
CX40529-1G	(S)-propargylglycinolhydrochloride	(S)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	1G	8200	chiralix
CX40529-2G	(S)-propargylglycinolhydrochloride	(S)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	2G	14000	chiralix
CX80916-500MG	bis(N-Cbz)-2-deoxystreptamine	benzyl4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	6216-32-6	430.45	C22H26N2O7	bis-Z-2-DOS	>95%	500MG	6200	chiralix
CX80916-1G	bis(N-Cbz)-2-deoxystreptamine	benzyl4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	6216-32-6	430.45	C22H26N2O7	bis-Z-2-DOS	>95%	1G	10800	chiralix
CX93851-100MG	(2S,5R)-5-hydroxypipecolicacidhydrochloride	(2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride	824943-40-0	181.62	C6H12ClNO3		>98%	100MG	3800	chiralix
CX93851-500MG	(2S,5R)-5-hydroxypipecolicacidhydrochloride	(2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride	824943-40-0	181.62	C6H12ClNO3		>98%	500MG	12600	chiralix
CX93851-1G	(2S,5R)-5-hydroxypipecolicacidhydrochloride	(2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride	824943-40-0	181.62	C6H12ClNO3		>98%	1G	19600	chiralix
CX19922-1G	(S)-beta3-phenylalaninemethylesterhydrochloride	(S)-methyl3-amino-3-phenylpropanoatehydrochloride	144494-72-4	215.68	C10H14ClNO2		>98%	1G	3000	chiralix
CX19922-2G	(S)-beta3-phenylalaninemethylesterhydrochloride	(S)-methyl3-amino-3-phenylpropanoatehydrochloride	144494-72-4	215.68	C10H14ClNO2		>98%	2G	5200	chiralix
CX19922-5G	(S)-beta3-phenylalaninemethylesterhydrochloride	(S)-methyl3-amino-3-phenylpropanoatehydrochloride	144494-72-4	215.68	C10H14ClNO2		>98%	5G	9800	chiralix
CX62577-10MG	6,8a-diepi-castanospermine	(1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol	106798-21-0	189.21	C8H15NO4		>98%	10MG	3600	chiralix
CX62577-50MG	6,8a-diepi-castanospermine	(1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol	106798-21-0	189.21	C8H15NO4		>98%	50MG	11800	chiralix
CX25404-1G	Fmoc-L-azidoornithine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoicacid	1097192-04-5	380.40	C20H20N4O4	Fmoc-Orn(N2)-OH	>98%	1G	3400	chiralix
CX25404-5G	Fmoc-L-azidoornithine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoicacid	1097192-04-5	380.40	C20H20N4O4	Fmoc-Orn(N2)-OH	>98%	5G	12000	chiralix
CX23880-5MG	rac-GR24	(3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one	76974-79-3	298.29	C17H14O5		>98%	5MG	5000	chiralix
CX23880-20MG	rac-GR24	(3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one	76974-79-3	298.29	C17H14O5		>98%	20MG	15000	chiralix
CX23880-100MG	rac-GR24	(3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one	76974-79-3	298.29	C17H14O5		>98%	100MG	35000	chiralix
CX38605-1G	Fmoc-L-allysineethyleneacetal	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	411.45	C23H25NO6	Fmoc-Aea-OH	>97%	1G	7200	chiralix
CX38605-2G	Fmoc-L-allysineethyleneacetal	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	411.45	C23H25NO6	Fmoc-Aea-OH	>97%	2G	12400	chiralix
CX59650-1G	Fmoc-L-azidohomoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoicacid	942518-20-9	366.37	C19H18N4O4	Fmoc-Azh-OH	>98%	1G	3400	chiralix
CX59650-5G	Fmoc-L-azidohomoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoicacid	942518-20-9	366.37	C19H18N4O4	Fmoc-Azh-OH	>98%	5G	12000	chiralix
CX94894-200MG	L-bishomopropargylglycine	(S)-2-aminohept-6-ynoicacid	835627-45-7	141.17	C7H11NO2	H-Bpg-OH	>98%	200MG	4400	chiralix
CX94894-500MG	L-bishomopropargylglycine	(S)-2-aminohept-6-ynoicacid	835627-45-7	141.17	C7H11NO2	H-Bpg-OH	>98%	500MG	9000	chiralix
CX94894-1G	L-bishomopropargylglycine	(S)-2-aminohept-6-ynoicacid	835627-45-7	141.17	C7H11NO2	H-Bpg-OH	>98%	1G	14600	chiralix
CX13745-1G	(R)-propargylglycinolhydrochloride	(R)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	1G	8200	chiralix
CX13745-2G	(R)-propargylglycinolhydrochloride	(R)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	2G	14000	chiralix
CX78500-1G	(R)-allylglycinolhydrochloride	(R)-2-aminopent-4-en-1-olhydrochloride	926660-30-2	137.61	C5H12ClNO		>98%	1G	7400	chiralix
CX78500-2G	(R)-allylglycinolhydrochloride	(R)-2-aminopent-4-en-1-olhydrochloride	926660-30-2	137.61	C5H12ClNO		>98%	2G	12800	chiralix
CX69324-500MG	bis(N-Boc)-2-deoxystreptamine	tert-butyl(1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	189157-45-7	362.42	C16H30N2O7	bis-Boc-2-DOS	>95%	500MG	6200	chiralix
CX69324-1G	bis(N-Boc)-2-deoxystreptamine	tert-butyl(1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	189157-45-7	362.42	C16H30N2O7	bis-Boc-2-DOS	>95%	1G	10800	chiralix
CX96388-1G	Boc-L-allysineethyleneacetal	(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	289.32	C13H23NO6	Boc-Aea-OH	>98%	1G	6200	chiralix
CX96388-2G	Boc-L-allysineethyleneacetal	(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	289.32	C13H23NO6	Boc-Aea-OH	>98%	2G	10600	chiralix
CX96388-5G	Boc-L-allysineethyleneacetal	(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	289.32	C13H23NO6	Boc-Aea-OH	>98%	5G	19900	chiralix
CX42388-1G	Cbz-L-allysineethyleneacetal	(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	852822-01-6	323.34	C16H21NO6	Z-Aea-OH	>98%	1G	6200	chiralix
CX42388-2G	Cbz-L-allysineethyleneacetal	(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	852822-01-6	323.34	C16H21NO6	Z-Aea-OH	>98%	2G	10600	chiralix
CX42388-5G	Cbz-L-allysineethyleneacetal	(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	852822-01-6	323.34	C16H21NO6	Z-Aea-OH	>98%	5G	19900	chiralix
CX44656-500MG	Boc-L-homopropargylglycine	(S)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	208522-16-1	227.26	C11H17NO4	Boc-Hpg-OH	>98%	500MG	9800	chiralix
CX44656-1G	Boc-L-homopropargylglycine	(S)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	208522-16-1	227.26	C11H17NO4	Boc-Hpg-OH	>98%	1G	16000	chiralix
CX69013-500MG	Cbz-L-homopropargylglycine	(S)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-Hpg-OH	>98%	500MG	9800	chiralix
CX69013-1G	Cbz-L-homopropargylglycine	(S)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-Hpg-OH	>98%	1G	16000	chiralix
CX54783-500MG	Boc-D-homopropargylglycine	(R)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	Notavailable	227.26	C11H17NO4	Boc-D-Hpg-OH	>98%	500MG	9800	chiralix
CX54783-1G	Boc-D-homopropargylglycine	(R)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	Notavailable	227.26	C11H17NO4	Boc-D-Hpg-OH	>98%	1G	16000	chiralix
CX14845-500MG	Cbz-D-homopropargylglycine	(R)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-D-Hpg-OH	>98%	500MG	9800	chiralix
CX14845-1G	Cbz-D-homopropargylglycine	(R)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-D-Hpg-OH	>98%	1G	16000	chiralix
CX87818-500MG	Fmoc-D-homopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	Notavailable	349.38	C21H19NO4	Fmoc-D-Hpg-OH	>97%	500MG	11200	chiralix
CX87818-1G	Fmoc-D-homopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	Notavailable	349.38	C21H19NO4	Fmoc-D-Hpg-OH	>97%	1G	18400	chiralix
CX57816-500MG	Fmoc-L-bishomopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-Bpg-OH	>97%	500MG	10400	chiralix
CX57816-1G	Fmoc-L-bishomopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-Bpg-OH	>97%	1G	16800	chiralix
CX32424-200MG	D-bishomopropargylglycine	(R)-2-aminohept-6-ynoicacid	211054-03-4	141.17	C7H11NO2	H-D-Bpg-OH	>98%	200MG	4400	chiralix
CX32424-500MG	D-bishomopropargylglycine	(R)-2-aminohept-6-ynoicacid	211054-03-4	141.17	C7H11NO2	H-D-Bpg-OH	>98%	500MG	9000	chiralix
CX32424-1G	D-bishomopropargylglycine	(R)-2-aminohept-6-ynoicacid	211054-03-4	141.17	C7H11NO2	H-D-Bpg-OH	>98%	1G	14600	chiralix
CX80846-500MG	Fmoc-D-bishomopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-D-Bpg-OH	>97%	500MG	10400	chiralix
CX80846-1G	Fmoc-D-bishomopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-D-Bpg-OH	>97%	1G	16800	chiralix
CX52977-1G	(S)-Boc-beta3-phenylalanine	(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid	103365-47-5	265.30	C14H19NO4		>98%	1G	2200	chiralix
CX52977-2G	(S)-Boc-beta3-phenylalanine	(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid	103365-47-5	265.30	C14H19NO4		>98%	2G	3800	chiralix
CX52977-5G	(S)-Boc-beta3-phenylalanine	(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid	103365-47-5	265.30	C14H19NO4		>98%	5G	7200	chiralix
CX79659-1G	(S)-Cbz-beta3-phenylalanine	(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid	14441-08-8	299.32	C17H17NO4		>98%	1G	2200	chiralix
CX79659-2G	(S)-Cbz-beta3-phenylalanine	(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid	14441-08-8	299.32	C17H17NO4		>98%	2G	3800	chiralix
CX79659-5G	(S)-Cbz-beta3-phenylalanine	(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid	14441-08-8	299.32	C17H17NO4		>98%	5G	7200	chiralix
CX56872-1G	(S)-Fmoc-beta3-phenylalanine	(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid	209252-15-3	387.43	C24H21NO4		>98%	1G	2600	chiralix
CX56872-2G	(S)-Fmoc-beta3-phenylalanine	(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid	209252-15-3	387.43	C24H21NO4		>98%	2G	4400	chiralix
CX56872-5G	(S)-Fmoc-beta3-phenylalanine	(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid	209252-15-3	387.43	C24H21NO4		>98%	5G	8600	chiralix
CX44048-1G	Boc-D-tert-leucine	(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid	124655-17-0	231.29	C11H21NO4	Boc-D-tert-Leu-OH	>98%	1G	2200	chiralix
CX44048-2G	Boc-D-tert-leucine	(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid	124655-17-0	231.29	C11H21NO4	Boc-D-tert-Leu-OH	>98%	2G	3800	chiralix
CX44048-5G	Boc-D-tert-leucine	(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid	124655-17-0	231.29	C11H21NO4	Boc-D-tert-Leu-OH	>98%	5G	7200	chiralix
CX22855-1G	Fmoc-D-tert-leucine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid	198543-64-5	353.41	C21H23NO4	Fmoc-D-tert-Leu-OH	>97%	1G	2600	chiralix
CX22855-2G	Fmoc-D-tert-leucine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid	198543-64-5	353.41	C21H23NO4	Fmoc-D-tert-Leu-OH	>97%	2G	4400	chiralix
CX22855-5G	Fmoc-D-tert-leucine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid	198543-64-5	353.41	C21H23NO4	Fmoc-D-tert-Leu-OH	>97%	5G	8600	chiralix
CX28901-1G	(S)-Boc-alpha-methyl-phenylglycine	(S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoicacid	802541-88-4	265.30	C14H19NO4	(S)-Boc-Mpg-OH	>98%	1G	9000	chiralix
CX28901-2G	(S)-Boc-alpha-methyl-phenylglycine	(S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoicacid	802541-88-4	265.30	C14H19NO4	(S)-Boc-Mpg-OH	>98%	2G	14800	chiralix
CX28344-1G	(S)-Fmoc-alpha-methyl-phenylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881921-11-5	387.43	C24H21NO4	(S)-Fmoc-Mpg-OH	>98%	1G	10400	chiralix
CX28344-2G	(S)-Fmoc-alpha-methyl-phenylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881921-11-5	387.43	C24H21NO4	(S)-Fmoc-Mpg-OH	>98%	2G	17200	chiralix
CX93005-1G	Fmoc-L-azidoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoicacid	684270-46-0	352.34	C18H16N4O4	Fmoc-Aza-OH	>98%	1G	3400	chiralix
CX93005-5G	Fmoc-L-azidoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoicacid	684270-46-0	352.34	C18H16N4O4	Fmoc-Aza-OH	>98%	5G	12000	chiralix
CX90286-200MG	bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine	4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate	90852-19-0	340.29	C12H16N6O6	2-DOSdiazidetriacetate	>98%	200MG	4200	chiralix
CX90286-500MG	bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine	4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate	90852-19-0	340.29	C12H16N6O6	2-DOSdiazidetriacetate	>98%	500MG	8800	chiralix
CX90286-1G	bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine	4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate	90852-19-0	340.29	C12H16N6O6	2-DOSdiazidetriacetate	>98%	1G	15200	chiralix
CX44848-200MG	(R)-4-oxopipecolicacidethyleneacetal	(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	200MG	5200	chiralix
CX44848-500MG	(R)-4-oxopipecolicacidethyleneacetal	(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	500MG	11000	chiralix
CX44848-1G	(R)-4-oxopipecolicacidethyleneacetal	(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	1G	19200	chiralix
CX45124-500MG	(R)-alpha-methyl-phenylglycine	(R)-2-amino-2-phenylpropanoicacid	29738-09-8	165.19	C9H11NO2	(R)-H-Mpg-OH	>98%	500MG	6200	chiralix
CX45124-1G	(R)-alpha-methyl-phenylglycine	(R)-2-amino-2-phenylpropanoicacid	29738-09-8	165.19	C9H11NO2	(R)-H-Mpg-OH	>98%	1G	10400	chiralix
CX45124-2G	(R)-alpha-methyl-phenylglycine	(R)-2-amino-2-phenylpropanoicacid	29738-09-8	165.19	C9H11NO2	(R)-H-Mpg-OH	>98%	2G	17200	chiralix
CX43844-1G	L-azidoleucineCHAsalt	cyclohexanaminium(S)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Leu-OH·CHA	>98%	1G	2800	chiralix
CX43844-5G	L-azidoleucineCHAsalt	cyclohexanaminium(S)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Leu-OH·CHA	>98%	5G	10600	chiralix
CX66793-1G	L-azidovalineCHAsalt	cyclohexanaminium(S)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-Val-OH·CHA	>98%	1G	2600	chiralix
CX66793-5G	L-azidovalineCHAsalt	cyclohexanaminium(S)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-Val-OH·CHA	>98%	5G	9800	chiralix
CX90285-1G	L-azidotryptophanCHAsalt	cyclohexanaminium(S)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-Trp-OH·CHA	>98%	1G	2400	chiralix
CX90285-5G	L-azidotryptophanCHAsalt	cyclohexanaminium(S)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-Trp-OH·CHA	>98%	5G	9000	chiralix
CX32182-1G	L-azidoalanineCHAsalt	cyclohexanaminium(S)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-Ala-OH·CHA	>98%	1G	2800	chiralix
CX32182-5G	L-azidoalanineCHAsalt	cyclohexanaminium(S)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-Ala-OH·CHA	>98%	5G	10600	chiralix
CX33085-1G	L-azidophenylalanineCHAsalt	cyclohexanaminium(S)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	N3-Phe-OH·CHA	>98%	1G	2400	chiralix
CX33085-5G	L-azidophenylalanineCHAsalt	cyclohexanaminium(S)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	N3-Phe-OH·CHA	>98%	5G	9000	chiralix
CX37236-1G	L-azidoisoleucineCHAsalt	cyclohexanaminium(2S,3S)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Ile-OH·CHA	>98%	1G	2800	chiralix
CX37236-5G	L-azidoisoleucineCHAsalt	cyclohexanaminium(2S,3S)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Ile-OH·CHA	>98%	5G	10600	chiralix
CX81236-1G	L-azidotyrosineCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-Tyr-OH·CHA	>97%	1G	2800	chiralix
CX81236-5G	L-azidotyrosineCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-Tyr-OH·CHA	>97%	5G	10600	chiralix
CX84940-1G	L-azidomethionineCHAsalt	cyclohexanaminium(S)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-Met-OH·CHA	>98%	1G	2600	chiralix
CX84940-5G	L-azidomethionineCHAsalt	cyclohexanaminium(S)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-Met-OH·CHA	>98%	5G	9800	chiralix
CX81456-200MG	(S)-5-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	200MG	5200	chiralix
CX81456-500MG	(S)-5-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	500MG	11000	chiralix
CX81456-1G	(S)-5-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	1G	19200	chiralix
CX80632-1G	L-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-Thr(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX80632-5G	L-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-Thr(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX59871-1G	L-azidoserineCHAsalt	cyclohexanaminium(S)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-Ser-OH·CHA	>98%	1G	2600	chiralix
CX59871-5G	L-azidoserineCHAsalt	cyclohexanaminium(S)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-Ser-OH·CHA	>98%	5G	9800	chiralix
CX20625-1G	L-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-Asp(OtBu)-OH·CHA	>98%	1G	2600	chiralix
CX20625-5G	L-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-Asp(OtBu)-OH·CHA	>98%	5G	9800	chiralix
CX24163-1G	L-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-Glu(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX24163-5G	L-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-Glu(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX68680-1G	L-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-Tyr(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX68680-5G	L-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-Tyr(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX55921-1G	L-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-Ser(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX55921-5G	L-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-Ser(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX54776-200MG	(S)-4-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	356073-54-6	187.19	C8H13NO4		>98%	200MG	5200	chiralix
CX54776-500MG	(S)-4-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	356073-54-6	187.19	C8H13NO4		>98%	500MG	11000	chiralix
CX54776-1G	(S)-4-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	356073-54-6	187.19	C8H13NO4		>98%	1G	19200	chiralix
CX46058-1G	D-azidovalineCHAsalt	cyclohexanaminium(R)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-D-Val-OH·CHA	>98%	1G	3000	chiralix
CX46058-5G	D-azidovalineCHAsalt	cyclohexanaminium(R)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-D-Val-OH·CHA	>98%	5G	11200	chiralix
CX44158-1G	D-azidoalanineCHAsalt	cyclohexanaminium(R)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-D-Ala-OH·CHA	>98%	1G	3400	chiralix
CX44158-5G	D-azidoalanineCHAsalt	cyclohexanaminium(R)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-D-Ala-OH·CHA	>98%	5G	12800	chiralix
CX27954-1G	D-azidophenylalanineCHAsalt	cyclohexanaminium(R)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	D-N3-Phe-OH·CHA	>98%	1G	2800	chiralix
CX27954-5G	D-azidophenylalanineCHAsalt	cyclohexanaminium(R)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	D-N3-Phe-OH·CHA	>98%	5G	10600	chiralix
CX56656-1G	D-azidomethionineCHAsalt	cyclohexanaminium(R)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-D-Met-OH·CHA	>98%	1G	2800	chiralix
CX56656-5G	D-azidomethionineCHAsalt	cyclohexanaminium(R)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-D-Met-OH·CHA	>98%	5G	10600	chiralix
CX16129-500MG	Cbz-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX16129-1G	Cbz-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX65817-1G	(S)-Cbz-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate	Notavailable	398.50	C23H30N2O4	(S)-Cbz-Mpg-OH·CHA	>98%	1G	9000	chiralix
CX65817-2G	(S)-Cbz-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate	Notavailable	398.50	C23H30N2O4	(S)-Cbz-Mpg-OH·CHA	>98%	2G	14800	chiralix
CX19691-500MG	Boc-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-D-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX19691-1G	Boc-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-D-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX59796-500MG	Boc-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX59796-1G	Boc-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX79723-1G	(R)-Fmoc-alpha-methyl-phenylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881920-86-1	387.43	C24H21NO4	(R)-Fmoc-Mpg-OH	>98%	1G	12000	chiralix
CX79723-2G	(R)-Fmoc-alpha-methyl-phenylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881920-86-1	387.43	C24H21NO4	(R)-Fmoc-Mpg-OH	>98%	2G	19800	chiralix
CX32015-1G	Cbz-D-tert-leucineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate	Notavailable	364.48	C20H32N2O4	Z-D-tert-Leu-OH·CHA	>98%	1G	2200	chiralix
CX32015-2G	Cbz-D-tert-leucineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate	Notavailable	364.48	C20H32N2O4	Z-D-tert-Leu-OH·CHA	>98%	2G	3800	chiralix
CX32015-5G	Cbz-D-tert-leucineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate	Notavailable	364.48	C20H32N2O4	Z-D-tert-Leu-OH·CHA	>98%	5G	7200	chiralix
CX81118-1G	Fmoc-L-azidolysine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoicacid	159610-89-6	394.42	C21H22N4O4	Fmoc-Lys(N2)-OH	>98%	1G	3400	chiralix
CX81118-5G	Fmoc-L-azidolysine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoicacid	159610-89-6	394.42	C21H22N4O4	Fmoc-Lys(N2)-OH	>98%	5G	12000	chiralix
CX19587-500MG	Cbz-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-D-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX19587-1G	Cbz-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-D-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX28021-500MG	H-Arg(Boc)2-pNA	(S,E)-tert-butyl(4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate	Notavailable	494.54	C22H34N6O7		>97%	500MG	6000	chiralix
CX28021-1G	H-Arg(Boc)2-pNA	(S,E)-tert-butyl(4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate	Notavailable	494.54	C22H34N6O7		>97%	1G	11000	chiralix
CX72798-1G	D-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-D-Asp(OtBu)-OH·CHA	>98%	1G	6200	chiralix
CX72798-5G	D-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-D-Asp(OtBu)-OH·CHA	>98%	5G	23400	chiralix
CX93516-1G	D-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-D-Glu(OtBu)-OH·CHA	>98%	1G	5200	chiralix
CX93516-5G	D-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-D-Glu(OtBu)-OH·CHA	>98%	5G	19600	chiralix
CX76762-1G	D-azidoleucineCHAsalt	cyclohexanaminium(R)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Leu-OH·CHA	>98%	1G	3000	chiralix
CX76762-5G	D-azidoleucineCHAsalt	cyclohexanaminium(R)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Leu-OH·CHA	>98%	5G	11200	chiralix
CX53333-1G	D-azidoisoleucineCHAsalt	cyclohexanaminium(2R,3R)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Ile-OH·CHA	>98%	1G	9200	chiralix
CX53333-2G	D-azidoisoleucineCHAsalt	cyclohexanaminium(2R,3R)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Ile-OH·CHA	>98%	2G	16400	chiralix
CX83245-1G	D-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-D-Tyr(OtBu)-OH·CHA	>98%	1G	5400	chiralix
CX83245-5G	D-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-D-Tyr(OtBu)-OH·CHA	>98%	5G	20400	chiralix
CX13425-1G	D-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-D-Ser(OtBu)-OH·CHA	>98%	1G	7200	chiralix
CX13425-5G	D-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-D-Ser(OtBu)-OH·CHA	>98%	5G	27200	chiralix
CX29937-1G	D-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-D-Thr(OtBu)-OH·CHA	>98%	1G	6400	chiralix
CX29937-5G	D-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-D-Thr(OtBu)-OH·CHA	>98%	5G	24200	chiralix
CX85233-1G	L-azidothreonineCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-Thr-OH·CHA	>98%	1G	2600	chiralix
CX85233-5G	L-azidothreonineCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-Thr-OH·CHA	>98%	5G	9800	chiralix
CX37313-1G	D-azidothreonineCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-D-Thr-OH·CHA	>98%	1G	3000	chiralix
CX37313-5G	D-azidothreonineCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-D-Thr-OH·CHA	>98%	5G	11200	chiralix
CX95405-1G	D-azidoserineCHAsalt	cyclohexanaminium(R)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-D-Ser-OH·CHA	>98%	1G	3200	chiralix
CX95405-5G	D-azidoserineCHAsalt	cyclohexanaminium(R)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-D-Ser-OH·CHA	>98%	5G	12000	chiralix
CX57717-1G	L-azidoglutamineDCHAsalt	dicyclohexylammonium(S)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-Gln-OH·DCHA	>98%	1G	2600	chiralix
CX57717-5G	L-azidoglutamineDCHAsalt	dicyclohexylammonium(S)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-Gln-OH·DCHA	>98%	5G	9800	chiralix
CX79807-1G	D-azidoglutamineDCHAsalt	dicyclohexylammonium(R)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-D-Gln-OH·DCHA	>98%	1G	3200	chiralix
CX79807-5G	D-azidoglutamineDCHAsalt	dicyclohexylammonium(R)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-D-Gln-OH·DCHA	>98%	5G	12000	chiralix
CX94556-1G	L-azidoasparagineDCHAsalt	dicyclohexylammonium(S)-4-amino-2-azido-4-oxobutanoate	79410-49-4	339.43	C16H29N5O3	N3-Asn-OH·DCHA	>98%	1G	3200	chiralix
CX94556-5G	L-azidoasparagineDCHAsalt	dicyclohexylammonium(S)-4-amino-2-azido-4-oxobutanoate	79410-49-4	339.43	C16H29N5O3	N3-Asn-OH·DCHA	>98%	5G	12000	chiralix
CX83100-1G	D-azidoasparagineDCHAsalt	dicyclohexylammonium(R)-4-amino-2-azido-4-oxobutanoate	Notavailable	339.43	C16H29N5O3	N3-D-Asn-OH·DCHA	>98%	1G	4000	chiralix
CX83100-5G	D-azidoasparagineDCHAsalt	dicyclohexylammonium(R)-4-amino-2-azido-4-oxobutanoate	Notavailable	339.43	C16H29N5O3	N3-D-Asn-OH·DCHA	>98%	5G	15000	chiralix
CX48141-1G	D-azidotryptophanCHAsalt	cyclohexanaminium(R)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-D-Trp-OH·CHA	>98%	1G	2600	chiralix
CX48141-5G	D-azidotryptophanCHAsalt	cyclohexanaminium(R)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-D-Trp-OH·CHA	>98%	5G	9800	chiralix
CX93426-1G	N-im-trityl-L-azidohistidineCHAsalt	cyclohexanaminium(S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate	Notavailable	522.64	C31H34N6O2	N3-His(Trt)-OH·CHA	>98%	1G	4000	chiralix
CX93426-5G	N-im-trityl-L-azidohistidineCHAsalt	cyclohexanaminium(S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate	Notavailable	522.64	C31H34N6O2	N3-His(Trt)-OH·CHA	>98%	5G	15000	chiralix
CX24279-1G	D-azidotyrosineCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-D-Tyr-OH·CHA	>98%	1G	3600	chiralix
CX24279-5G	D-azidotyrosineCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-D-Tyr-OH·CHA	>98%	5G	13600	chiralix
CX78063-1G	L-azido-tert-leucineCHAsalt	cyclohexanaminium(S)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-tert-Leu-OH·CHA	>98%	1G	2800	chiralix
CX78063-5G	L-azido-tert-leucineCHAsalt	cyclohexanaminium(S)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-tert-Leu-OH·CHA	>98%	5G	10600	chiralix
CX30547-1G	D-azido-tert-leucineCHAsalt	cyclohexanaminium(R)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-D-tert-Leu-OH·CHA	>98%	1G	6600	chiralix
CX30547-5G	D-azido-tert-leucineCHAsalt	cyclohexanaminium(R)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-D-tert-Leu-OH·CHA	>98%	5G	25000	chiralix
CX78942-1G	L-azidoallylglycineCHAsalt	cyclohexanaminium(S)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-Alg-OH·CHA	>98%	1G	5600	chiralix
CX78942-5G	L-azidoallylglycineCHAsalt	cyclohexanaminium(S)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-Alg-OH·CHA	>98%	5G	21200	chiralix
CX61332-1G	D-azidoallylglycineCHAsalt	cyclohexanaminium(R)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-D-Alg-OH·CHA	>98%	1G	9000	chiralix
CX61332-2G	D-azidoallylglycineCHAsalt	cyclohexanaminium(R)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-D-Alg-OH·CHA	>98%	2G	16000	chiralix
CX56925-1G	Ng-Pmc-L-azidoarginine	(S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoicacid	Notavailable	466.55	C20H30N6O5S	Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine	>95%	1G	4000	chiralix
CX56925-5G	Ng-Pmc-L-azidoarginine	(S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoicacid	Notavailable	466.55	C20H30N6O5S	Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine	>95%	5G	15000	chiralix
CX22361-1G	(S)-azido-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(S)-N3-Mpg-OH·CHA	>98%	1G	9000	chiralix
CX22361-2G	(S)-azido-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(S)-N3-Mpg-OH·CHA	>98%	2G	14800	chiralix
CX52265-1G	(R)-azido-alpha-methylphenylglycineCHAsalt	cyclohexanaminium(R)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(R)-N3-Mpg-OH·CHA	>98%	1G	10400	chiralix
CX52265-2G	(R)-azido-alpha-methylphenylglycineCHAsalt	cyclohexanaminium(R)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(R)-N3-Mpg-OH·CHA	>98%	2G	17200	chiralix
CX71813-1G	S-Trityl-L-azidocysteineCHAsalt	cyclohexanaminium(R)-2-azido-3-(tritylthio)propanoate	Notavailable	488.64	C28H32N4O2S	N3-Cys(Trt)-OH·CHA	>98%	1G	3000	chiralix
CX71813-5G	S-Trityl-L-azidocysteineCHAsalt	cyclohexanaminium(R)-2-azido-3-(tritylthio)propanoate	Notavailable	488.64	C28H32N4O2S	N3-Cys(Trt)-OH·CHA	>98%	5G	11200	chiralix
CX40608-5G	6-azidohexanoicacid	6-azidohexanoicacid	79598-53-1	157.17	C6H11N3O2		>98%	5G	6000	chiralix
CX40608-10G	6-azidohexanoicacid	6-azidohexanoicacid	79598-53-1	157.17	C6H11N3O2		>98%	10G	11000	chiralix
CX23053-500MG	(S)-bishomopropargylglycinolhydrochloride	(S)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	500MG	10400	chiralix
CX23053-1G	(S)-bishomopropargylglycinolhydrochloride	(S)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	1G	17200	chiralix
CX63523-500MG	(R)-bishomopropargylglycinolhydrochloride	(R)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	500MG	10400	chiralix
CX63523-1G	(R)-bishomopropargylglycinolhydrochloride	(R)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	1G	17200	chiralix
CX69091-500MG	(R)-homopropargylglycinolhydrochloride	(R)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	500MG	11000	chiralix
CX69091-1G	(R)-homopropargylglycinolhydrochloride	(R)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	1G	17800	chiralix
CX76358-500MG	(S)-homopropargylglycinolhydrochloride	(S)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	500MG	11000	chiralix
CX76358-1G	(S)-homopropargylglycinolhydrochloride	(S)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	1G	17800	chiralix
CX55029-2MG	cereulide	cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3	Notavailable	1153.40	C57H96N6O18		>95%	2MG	12000	chiralix
CX55029-5MG	cereulide	cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3	Notavailable	1153.40	C57H96N6O18		>95%	5MG	24000	chiralix
CX45120-1G	H-Orn(Boc)-pNA	(S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate	Notavailable	352.39	C16H24N4O5		>98%	1G	4000	chiralix
CX45120-2G	H-Orn(Boc)-pNA	(S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate	Notavailable	352.39	C16H24N4O5		>98%	2G	9000	chiralix
CX45120-5G	H-Orn(Boc)-pNA	(S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate	Notavailable	352.39	C16H24N4O5		>98%	5G	15000	chiralix
CX57163-2MG	13C6-cereulide	cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3	Notavailable	1159.36	C5113C6H96N6O18		>95%	2MG	24000	chiralix
CX64158-1G	Fmoc-Orn-pNA·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	510.97	C26H27ClN4O5	Fmoc-Orn-pNAHClsalt	>98%	1G	4000	chiralix
CX64158-2G	Fmoc-Orn-pNA·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	510.97	C26H27ClN4O5	Fmoc-Orn-pNAHClsalt	>98%	2G	7200	chiralix
CX64158-5G	Fmoc-Orn-pNA·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	510.97	C26H27ClN4O5	Fmoc-Orn-pNAHClsalt	>98%	5G	15000	chiralix
CX80044-250MG	Bis(H-Orn(Boc))-rhodamine110	Bis(H-Orn(Boc))-rhodamine	Notavailable	758.86	C40H50N6O9		>95%	250MG	7600	chiralix
CX80044-500MG	Bis(H-Orn(Boc))-rhodamine110	Bis(H-Orn(Boc))-rhodamine	Notavailable	758.86	C40H50N6O9		>95%	500MG	14000	chiralix
CX80044-1G	Bis(H-Orn(Boc))-rhodamine110	Bis(H-Orn(Boc))-rhodamine	Notavailable	758.86	C40H50N6O9		>95%	1G	25000	chiralix
CX67830-250MG	Bis(H-Arg(Boc)2)-rhodamine110	Bis(H-Arg(Boc)2)-rhodamine	Notavailable	1043.17	C52H70N10O13		>95%	250MG	7800	chiralix
CX67830-500MG	Bis(H-Arg(Boc)2)-rhodamine110	Bis(H-Arg(Boc)2)-rhodamine	Notavailable	1043.17	C52H70N10O13		>95%	500MG	14400	chiralix
CX67830-1G	Bis(H-Arg(Boc)2)-rhodamine110	Bis(H-Arg(Boc)2)-rhodamine	Notavailable	1043.17	C52H70N10O13		>95%	1G	26000	chiralix
CX18326-1G	Fmoc-Orn-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	548.03	C30H30ClN3O5		>98%	1G	5000	chiralix
CX18326-2G	Fmoc-Orn-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	548.03	C30H30ClN3O5		>98%	2G	9000	chiralix
CX18326-5G	Fmoc-Orn-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	548.03	C30H30ClN3O5		>98%	5G	19000	chiralix
CX59077-1G	H-Orn(Boc)-AMC	(S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate	Notavailable	389.45	C20H27N3O5		>98%	1G	6000	chiralix
CX59077-2G	H-Orn(Boc)-AMC	(S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate	Notavailable	389.45	C20H27N3O5		>98%	2G	10800	chiralix
CX59077-5G	H-Orn(Boc)-AMC	(S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate	Notavailable	389.45	C20H27N3O5		>98%	5G	22000	chiralix
CX48623-1G	H-Lys(Boc)-AMC	(S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate	222037-62-9	403.47	C21H29N3O5		>98%	1G	5000	chiralix
CX48623-2G	H-Lys(Boc)-AMC	(S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate	222037-62-9	403.47	C21H29N3O5		>98%	2G	9000	chiralix
CX48623-5G	H-Lys(Boc)-AMC	(S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate	222037-62-9	403.47	C21H29N3O5		>98%	5G	19000	chiralix
CX55361-500MG	H-Arg(Boc)2-AMC	H-Arg(Boc)2-AMC	Notavailable	531.60	C26H37N5O7		>97%	500MG	6000	chiralix
CX55361-1G	H-Arg(Boc)2-AMC	H-Arg(Boc)2-AMC	Notavailable	531.60	C26H37N5O7		>97%	1G	10800	chiralix
CX84944-1G	Fmoc-Lys-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride	Notavailable	562.06	C31H32ClN3O5		>98%	1G	4000	chiralix
CX84944-2G	Fmoc-Lys-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride	Notavailable	562.06	C31H32ClN3O5		>98%	2G	7200	chiralix
CX84944-5G	Fmoc-Lys-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride	Notavailable	562.06	C31H32ClN3O5		>98%	5G	15000	chiralix
CX69359-5G	4-azidobutyricacid	4-azidobutanoicacid	54447-68-6	129.12	C4H7N3O2	gamma-azidobutyricacid	>98%	5G	6000	chiralix
CX69359-10G	4-azidobutyricacid	4-azidobutanoicacid	54447-68-6	129.12	C4H7N3O2	gamma-azidobutyricacid	>98%	10G	11000	chiralix
CX31309-5G	5-azidovalericacid	5-azidopentanoicacid	79583-98-5	143.14	C5H9N3O2	delta-azidovalericacid	>98%	5G	6600	chiralix
CX31309-10G	5-azidovalericacid	5-azidopentanoicacid	79583-98-5	143.14	C5H9N3O2	delta-azidovalericacid	>98%	10G	11800	chiralix
CX98490-5G	7-azidoheptanoicacid	7-azidoheptanoicacid	135920-28-4	171.20	C7H13N3O2		>98%	5G	6000	chiralix
CX98490-10G	7-azidoheptanoicacid	7-azidoheptanoicacid	135920-28-4	171.20	C7H13N3O2		>98%	10G	11000	chiralix
CX65527-1G	6-methylcyclohex-1-enecarboxylicacid	6-methylcyclohex-1-enecarboxylicacid	5726-56-7	140.18	C8H12O2		>98%	1G	2800	chiralix
CX65527-5G	6-methylcyclohex-1-enecarboxylicacid	6-methylcyclohex-1-enecarboxylicacid	5726-56-7	140.18	C8H12O2		>98%	5G	10600	chiralix
CX65527-10G	6-methylcyclohex-1-enecarboxylicacid	6-methylcyclohex-1-enecarboxylicacid	5726-56-7	140.18	C8H12O2		>98%	10G	17000	chiralix
CX61074-200MG	(S)-beta2-homoalanineHClsalt	(S)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(S)-beta2-hAla-OH·HCl	>98%	200MG	4800	chiralix
CX61074-500MG	(S)-beta2-homoalanineHClsalt	(S)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(S)-beta2-hAla-OH·HCl	>98%	500MG	9800	chiralix
CX61074-1G	(S)-beta2-homoalanineHClsalt	(S)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(S)-beta2-hAla-OH·HCl	>98%	1G	16000	chiralix
CX39389-200MG	(R)-beta2-homoalanineHClsalt	(R)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(R)-beta2-hAla-OH·HCl	>98%	200MG	4800	chiralix
CX39389-500MG	(R)-beta2-homoalanineHClsalt	(R)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(R)-beta2-hAla-OH·HCl	>98%	500MG	9800	chiralix
CX39389-1G	(R)-beta2-homoalanineHClsalt	(R)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(R)-beta2-hAla-OH·HCl	>98%	1G	16000	chiralix
CX80391-200MG	(R)-beta2-homoleucineHClsalt	(R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(R)-beta2-hLeu-OH·HCl	>98%	200MG	4800	chiralix
CX80391-500MG	(R)-beta2-homoleucineHClsalt	(R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(R)-beta2-hLeu-OH·HCl	>98%	500MG	9800	chiralix
CX80391-1G	(R)-beta2-homoleucineHClsalt	(R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(R)-beta2-hLeu-OH·HCl	>98%	1G	16000	chiralix
CX82876-200MG	(R)-beta2-homovalineHClsalt	(R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(R)-beta2-hVal-OH·HCl	>98%	200MG	4800	chiralix
CX82876-500MG	(R)-beta2-homovalineHClsalt	(R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(R)-beta2-hVal-OH·HCl	>98%	500MG	9800	chiralix
CX82876-1G	(R)-beta2-homovalineHClsalt	(R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(R)-beta2-hVal-OH·HCl	>98%	1G	16000	chiralix
CX93488-1MG	(±)-sorgolactone	(3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	Notavailable	316.35	C18H20O5	racemicsorgolactone	>98%	1MG	4000	chiralix
CX93488-5MG	(±)-sorgolactone	(3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	Notavailable	316.35	C18H20O5	racemicsorgolactone	>98%	5MG	15000	chiralix
CX64382-1MG	(±)-strigol	(3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	51820-11-2	346.37	C19H22O6		>98%	1MG	5000	chiralix
CX64382-5MG	(±)-strigol	(3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	51820-11-2	346.37	C19H22O6		>98%	5MG	18800	chiralix
CX88057-10MG	Nijmegen-1	(Z)-methyl2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate	159155-03-0	343.29	C17H13NO7		>98%	10MG	3600	chiralix
CX88057-50MG	Nijmegen-1	(Z)-methyl2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate	159155-03-0	343.29	C17H13NO7		>98%	50MG	11800	chiralix
CX42450-200MG	(S)-beta2-homophenylalanineHClsalt	(S)-3-amino-2-benzylpropanoicacidhydrochloride	1010806-95-7	215.68	C10H14ClNO2	(S)-beta2-hPhe-OH·HCl	>98%	200MG	4800	chiralix
CX42450-500MG	(S)-beta2-homophenylalanineHClsalt	(S)-3-amino-2-benzylpropanoicacidhydrochloride	1010806-95-7	215.68	C10H14ClNO2	(S)-beta2-hPhe-OH·HCl	>98%	500MG	9800	chiralix
CX42450-1G	(S)-beta2-homophenylalanineHClsalt	(S)-3-amino-2-benzylpropanoicacidhydrochloride	1010806-95-7	215.68	C10H14ClNO2	(S)-beta2-hPhe-OH·HCl	>98%	1G	16000	chiralix
CX35419-200MG	(S)-beta2-homovalineHClsalt	(S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(S)-beta2-hVal-OH·HCl	>98%	200MG	4800	chiralix
CX35419-500MG	(S)-beta2-homovalineHClsalt	(S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(S)-beta2-hVal-OH·HCl	>98%	500MG	9800	chiralix
CX35419-1G	(S)-beta2-homovalineHClsalt	(S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(S)-beta2-hVal-OH·HCl	>98%	1G	16000	chiralix
CX11583-200MG	(R)-beta2-homophenylalanineHClsalt	(R)-3-amino-2-benzylpropanoicacidhydrochloride	Notavailable	215.68	C10H14ClNO2	(R)-beta2-hPhe-OH·HCl	>98%	200MG	4800	chiralix
CX11583-500MG	(R)-beta2-homophenylalanineHClsalt	(R)-3-amino-2-benzylpropanoicacidhydrochloride	Notavailable	215.68	C10H14ClNO2	(R)-beta2-hPhe-OH·HCl	>98%	500MG	9800	chiralix
CX11583-1G	(R)-beta2-homophenylalanineHClsalt	(R)-3-amino-2-benzylpropanoicacidhydrochloride	Notavailable	215.68	C10H14ClNO2	(R)-beta2-hPhe-OH·HCl	>98%	1G	16000	chiralix
CX92224-200MG	(S)-beta2-homoleucineHClsalt	(S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(S)-beta2-hLeu-OH·HCl	>98%	200MG	4800	chiralix
CX92224-500MG	(S)-beta2-homoleucineHClsalt	(S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(S)-beta2-hLeu-OH·HCl	>98%	500MG	9800	chiralix
CX92224-1G	(S)-beta2-homoleucineHClsalt	(S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(S)-beta2-hLeu-OH·HCl	>98%	1G	16000	chiralix
CX81018-500MG	(S)-Fmoc-beta2-homoalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	203854-58-4	325.36	C19H19NO4	(S)-Fmoc-beta2-hAla-OH	>98%	500MG	11200	chiralix
CX81018-1G	(S)-Fmoc-beta2-homoalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	203854-58-4	325.36	C19H19NO4	(S)-Fmoc-beta2-hAla-OH	>98%	1G	18400	chiralix
CX85919-500MG	(R)-Fmoc-beta2-homoalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	Notavailable	325.36	C19H19NO4	(R)-Fmoc-beta2-hAla-OH	>98%	500MG	11200	chiralix
CX85919-1G	(R)-Fmoc-beta2-homoalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	Notavailable	325.36	C19H19NO4	(R)-Fmoc-beta2-hAla-OH	>98%	1G	18400	chiralix
CX98774-500MG	(R)-Fmoc-beta2-homoleucine	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	1018899-99-4	367.44	C22H25NO4	(R)-Fmoc-beta2-hLeu-OH	>98%	500MG	11200	chiralix
CX98774-1G	(R)-Fmoc-beta2-homoleucine	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	1018899-99-4	367.44	C22H25NO4	(R)-Fmoc-beta2-hLeu-OH	>98%	1G	18400	chiralix
CX33604-500MG	(R)-Fmoc-beta2-homovaline	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	Notavailable	353.41	C21H23NO4	(R)-Fmoc-beta2-hVal-OH	>98%	500MG	11200	chiralix
CX33604-1G	(R)-Fmoc-beta2-homovaline	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	Notavailable	353.41	C21H23NO4	(R)-Fmoc-beta2-hVal-OH	>98%	1G	18400	chiralix
CX82946-500MG	(S)-Fmoc-beta2-homophenylalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	203854-62-0	401.45	C25H23NO4	(S)-Fmoc-beta2-hPhe-OH	>98%	500MG	11200	chiralix
CX82946-1G	(S)-Fmoc-beta2-homophenylalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	203854-62-0	401.45	C25H23NO4	(S)-Fmoc-beta2-hPhe-OH	>98%	1G	18400	chiralix
CX86231-500MG	(S)-Fmoc-beta2-homovaline	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	203854-59-5	353.41	C21H23NO4	(S)-Fmoc-beta2-hVal-OH	>98%	500MG	11200	chiralix
CX86231-1G	(S)-Fmoc-beta2-homovaline	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	203854-59-5	353.41	C21H23NO4	(S)-Fmoc-beta2-hVal-OH	>98%	1G	18400	chiralix
CX15046-500MG	(R)-Fmoc-beta2-homophenylalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	828254-16-6	401.45	C25H23NO4	(R)-Fmoc-beta2-hPhe-OH	>98%	500MG	11200	chiralix
CX15046-1G	(R)-Fmoc-beta2-homophenylalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	828254-16-6	401.45	C25H23NO4	(R)-Fmoc-beta2-hPhe-OH	>98%	1G	18400	chiralix
CX30199-500MG	(S)-Fmoc-beta2-homoleucine	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	193887-45-5	367.44	C22H25NO4	(S)-Fmoc-beta2-hLeu-OH	>98%	500MG	11200	chiralix
CX30199-1G	(S)-Fmoc-beta2-homoleucine	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	193887-45-5	367.44	C22H25NO4	(S)-Fmoc-beta2-hLeu-OH	>98%	1G	18400	chiralix
CX20422-1ML	cereulide(50µg/mLinacetonitrile)	cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3(50µg/mLinacetonitrile)	Notavailable	1153.40	C57H96N6O18	cereulidestocksolution	>95%	1ML	5000	chiralix
CX87778-1ML	13C6-cereulide(20µg/mLinacetonitrile)	cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3(20µg/mLinacetonitrile)	Notavailable	1159.36	C5113C6H96N6O18	13C6-cereulidestocksolution	>95%	1ML	5000	chiralix
CX18112-1G	4-(azidomethyl)benzoicacid	4-(azidomethyl)benzoicacid	79584-03-5	177.16	C8H7N3O2		>98%	1G	3000	chiralix
CX18112-5G	4-(azidomethyl)benzoicacid	4-(azidomethyl)benzoicacid	79584-03-5	177.16	C8H7N3O2		>98%	5G	7400	chiralix
CX18112-10G	4-(azidomethyl)benzoicacid	4-(azidomethyl)benzoicacid	79584-03-5	177.16	C8H7N3O2		>98%	10G	13200	chiralix
CX95981-5G	2,2,2-trichloroethoxysulfonylchloride	2,2,2-trichloroethoxysulfonylchloride	764-09-0	247.91	C2H2Cl4O2S	chlorosulfuricacid2,2,2-trichloroethylester	>98%	5G	2200	chiralix
CX95981-10G	2,2,2-trichloroethoxysulfonylchloride	2,2,2-trichloroethoxysulfonylchloride	764-09-0	247.91	C2H2Cl4O2S	chlorosulfuricacid2,2,2-trichloroethylester	>98%	10G	4000	chiralix
CX95981-25G	2,2,2-trichloroethoxysulfonylchloride	2,2,2-trichloroethoxysulfonylchloride	764-09-0	247.91	C2H2Cl4O2S	chlorosulfuricacid2,2,2-trichloroethylester	>98%	25G	8400	chiralix
CX62483-1G	2-(azidomethyl)benzoicacid	2-(azidomethyl)benzoicacid	289712-57-8	177.16	C8H7N3O2		>98%	1G	4200	chiralix
CX62483-2G	2-(azidomethyl)benzoicacid	2-(azidomethyl)benzoicacid	289712-57-8	177.16	C8H7N3O2		>98%	2G	7600	chiralix
CX62483-5G	2-(azidomethyl)benzoicacid	2-(azidomethyl)benzoicacid	289712-57-8	177.16	C8H7N3O2		>98%	5G	16000	chiralix
CX80461-1G	3-(azidomethyl)benzoicacid	3-(azidomethyl)benzoicacid	905973-32-2	177.16	C8H7N3O2		>98%	1G	4200	chiralix
CX80461-2G	3-(azidomethyl)benzoicacid	3-(azidomethyl)benzoicacid	905973-32-2	177.16	C8H7N3O2		>98%	2G	7600	chiralix
CX80461-5G	3-(azidomethyl)benzoicacid	3-(azidomethyl)benzoicacid	905973-32-2	177.16	C8H7N3O2		>98%	5G	16000	chiralix
CX27597-1G	2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazoliumtriflate	2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-iumtrifluoromethanesulfonate	1185733-70-3	457.66	C8H10Cl3F3N2O6S2		>98%	1G	2600	chiralix
CX27597-5G	2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazoliumtriflate	2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-iumtrifluoromethanesulfonate	1185733-70-3	457.66	C8H10Cl3F3N2O6S2		>98%	5G	9800	chiralix
CX50506-10MG	TIS108	6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one	Notavailable	335.40	C20H21N3O2		>98%	10MG	3600	chiralix
CX50506-50MG	TIS108	6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one	Notavailable	335.40	C20H21N3O2		>98%	50MG	13800	chiralix
CX50506-100MG	TIS108	6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one	Notavailable	335.40	C20H21N3O2		>98%	100MG	23000	chiralix
CX95469-10MG	4-Brdebranone	5-(4-bromophenoxy)-3-methylfuran-2(5H)-one	1332863-94-1	269.09	C11H9BrO3	4BD	>98%	10MG	3000	chiralix
CX95469-50MG	4-Brdebranone	5-(4-bromophenoxy)-3-methylfuran-2(5H)-one	1332863-94-1	269.09	C11H9BrO3	4BD	>98%	50MG	11400	chiralix
CX95469-100MG	4-Brdebranone	5-(4-bromophenoxy)-3-methylfuran-2(5H)-one	1332863-94-1	269.09	C11H9BrO3	4BD	>98%	100MG	19600	chiralix
CX75854-10MG	4-CNdebranone	5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one	1332863-97-4	215.20	C12H9NO3		>98%	10MG	3000	chiralix
CX75854-50MG	4-CNdebranone	5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one	1332863-97-4	215.20	C12H9NO3		>98%	50MG	11400	chiralix
CX75854-100MG	4-CNdebranone	5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one	1332863-97-4	215.20	C12H9NO3		>98%	100MG	19600	chiralix
CX52612-10MG	Abamineoxalicacidsalt	(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate	Notavailable	463.45	C23H26FNO8		>98%	10MG	3000	chiralix
CX52612-50MG	Abamineoxalicacidsalt	(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate	Notavailable	463.45	C23H26FNO8		>98%	50MG	11400	chiralix
CX52612-100MG	Abamineoxalicacidsalt	(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate	Notavailable	463.45	C23H26FNO8		>98%	100MG	19600	chiralix
CX93797-10G	Fmoc-D-cyclohexylglycine	(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	198543-96-3	379.45	C23H25NO4	Fmoc-D-Chg-OH	>97%	10G	6000	chiralix
CX93797-25G	Fmoc-D-cyclohexylglycine	(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	198543-96-3	379.45	C23H25NO4	Fmoc-D-Chg-OH	>97%	25G	13000	chiralix
CX29693-10G	Fmoc-L-cyclohexylglycine	(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	161321-36-4	379.45	C23H25NO4	Fmoc-L-Chg-OH	>97%	10G	6000	chiralix
CX29693-25G	Fmoc-L-cyclohexylglycine	(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	161321-36-4	379.45	C23H25NO4	Fmoc-L-Chg-OH	>97%	25G	13000	chiralix 货号 品名 化学名 CAS号 分子量 分子式 Synonyms 纯度 包装 价格 品牌 CX90418-1G L-allysineethyleneacetal (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid 215054-80-1 189.21 C8H15NO4 H-Aea-OH 99% 1G 6200 chiralix CX90418-2G L-allysineethyleneacetal (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid 215054-80-1 189.21 C8H15NO4 H-Aea-OH 99% 2G 10600 chiralix CX90418-5G L-allysineethyleneacetal (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid 215054-80-1 189.21 C8H15NO4 H-Aea-OH 99% 5G 19900 chiralix CX60325-200MG D-homopropargylglycine (R)-2-aminohex-5-ynoicacid 211054-02-3 127.14 C6H9NO2 H-D-Hpg-OH >98% 200MG 4800 chiralix CX60325-500MG D-homopropargylglycine (R)-2-aminohex-5-ynoicacid 211054-02-3 127.14 C6H9NO2 H-D-Hpg-OH >98% 500MG 9800 chiralix CX60325-1G D-homopropargylglycine (R)-2-aminohex-5-ynoicacid 211054-02-3 127.14 C6H9NO2 H-D-Hpg-OH >98% 1G 16000 chiralix CX80065-500MG Fmoc-L-homopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid 942518-21-0 349.38 C21H19NO4 Fmoc-Hpg-OH >97% 500MG 11200 chiralix CX80065-1G Fmoc-L-homopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid 942518-21-0 349.38 C21H19NO4 Fmoc-Hpg-OH >97% 1G 18400 chiralix CX90138-200MG L-homopropargylglycine (S)-2-aminohex-5-ynoicacid 98891-36-2 127.14 C6H9NO2 H-Hpg-OH >98% 200MG 4800 chiralix CX90138-500MG L-homopropargylglycine (S)-2-aminohex-5-ynoicacid 98891-36-2 127.14 C6H9NO2 H-Hpg-OH >98% 500MG 9800 chiralix CX90138-1G L-homopropargylglycine (S)-2-aminohex-5-ynoicacid 98891-36-2 127.14 C6H9NO2 H-Hpg-OH >98% 1G 16000 chiralix CX56292-500MG (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid 108646-25-9 156.14 C7H8O4 >97% 500MG 6000 chiralix CX56292-1G (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid 108646-25-9 156.14 C7H8O4 >97% 1G 9800 chiralix CX24022-500MG (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid 38127-17-2 155.15 C7H9NO3 >98% 500MG 6000 chiralix CX24022-1G (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid 38127-17-2 155.15 C7H9NO3 >98% 1G 9800 chiralix CX41399-1G (S)-beta3-phenylalanine (S)-3-amino-3-phenylpropanoicacid 40856-44-8 165.19 C9H11NO2 99% 1G 2200 chiralix CX41399-2G (S)-beta3-phenylalanine (S)-3-amino-3-phenylpropanoicacid 40856-44-8 165.19 C9H11NO2 99% 2G 3800 chiralix CX41399-5G (S)-beta3-phenylalanine (S)-3-amino-3-phenylpropanoicacid 40856-44-8 165.19 C9H11NO2 99% 5G 7200 chiralix CX64691-1G D-tert-leucine (R)-2-amino-3,3-dimethylbutyricacid 26782-71-8 131.17 C6H13NO2 H-D-tert-Leu-OH 99% 1G 2200 chiralix CX64691-2G D-tert-leucine (R)-2-amino-3,3-dimethylbutyricacid 26782-71-8 131.17 C6H13NO2 H-D-tert-Leu-OH 99% 2G 3800 chiralix CX64691-5G D-tert-leucine (R)-2-amino-3,3-dimethylbutyricacid 26782-71-8 131.17 C6H13NO2 H-D-tert-Leu-OH 99% 5G 7200 chiralix CX97471-500MG (S)-alpha-methyl-phenylglycine (S)-2-amino-2-phenylpropanoicacid 13398-26-0 165.19 C9H11NO2 (S)-H-Mpg-OH >98% 500MG 5200 chiralix CX97471-1G (S)-alpha-methyl-phenylglycine (S)-2-amino-2-phenylpropanoicacid 13398-26-0 165.19 C9H11NO2 (S)-H-Mpg-OH >98% 1G 9000 chiralix CX97471-2G (S)-alpha-methyl-phenylglycine (S)-2-amino-2-phenylpropanoicacid 13398-26-0 165.19 C9H11NO2 (S)-H-Mpg-OH >98% 2G 14800 chiralix CX58692-1G (S)-allylglycinolhydrochloride (S)-2-aminopent-4-en-1-olhydrochloride 926660-03-9 137.61 C5H12ClNO >98% 1G 7400 chiralix CX58692-2G (S)-allylglycinolhydrochloride (S)-2-aminopent-4-en-1-olhydrochloride 926660-03-9 137.61 C5H12ClNO >98% 2G 12800 chiralix CX40529-1G (S)-propargylglycinolhydrochloride (S)-2-aminopent-4-yn-1-olhydrochloride Notavailable 135.59 C5H10ClNO >98% 1G 8200 chiralix CX40529-2G (S)-propargylglycinolhydrochloride (S)-2-aminopent-4-yn-1-olhydrochloride Notavailable 135.59 C5H10ClNO >98% 2G 14000 chiralix CX80916-500MG bis(N-Cbz)-2-deoxystreptamine benzyl4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 6216-32-6 430.45 C22H26N2O7 bis-Z-2-DOS >95% 500MG 6200 chiralix CX80916-1G bis(N-Cbz)-2-deoxystreptamine benzyl4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 6216-32-6 430.45 C22H26N2O7 bis-Z-2-DOS >95% 1G 10800 chiralix CX93851-100MG (2S,5R)-5-hydroxypipecolicacidhydrochloride (2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride 824943-40-0 181.62 C6H12ClNO3 >98% 100MG 3800 chiralix CX93851-500MG (2S,5R)-5-hydroxypipecolicacidhydrochloride (2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride 824943-40-0 181.62 C6H12ClNO3 >98% 500MG 12600 chiralix CX93851-1G (2S,5R)-5-hydroxypipecolicacidhydrochloride (2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride 824943-40-0 181.62 C6H12ClNO3 >98% 1G 19600 chiralix CX19922-1G (S)-beta3-phenylalaninemethylesterhydrochloride (S)-methyl3-amino-3-phenylpropanoatehydrochloride 144494-72-4 215.68 C10H14ClNO2 >98% 1G 3000 chiralix CX19922-2G (S)-beta3-phenylalaninemethylesterhydrochloride (S)-methyl3-amino-3-phenylpropanoatehydrochloride 144494-72-4 215.68 C10H14ClNO2 >98% 2G 5200 chiralix CX19922-5G (S)-beta3-phenylalaninemethylesterhydrochloride (S)-methyl3-amino-3-phenylpropanoatehydrochloride 144494-72-4 215.68 C10H14ClNO2 >98% 5G 9800 chiralix CX62577-10MG 6,8a-diepi-castanospermine (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol 106798-21-0 189.21 C8H15NO4 >98% 10MG 3600 chiralix CX62577-50MG 6,8a-diepi-castanospermine (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol 106798-21-0 189.21 C8H15NO4 >98% 50MG 11800 chiralix CX25404-1G Fmoc-L-azidoornithine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoicacid 1097192-04-5 380.40 C20H20N4O4 Fmoc-Orn(N2)-OH >98% 1G 3400 chiralix CX25404-5G Fmoc-L-azidoornithine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoicacid 1097192-04-5 380.40 C20H20N4O4 Fmoc-Orn(N2)-OH >98% 5G 12000 chiralix CX23880-5MG rac-GR24 (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one 76974-79-3 298.29 C17H14O5 >98% 5MG 5000 chiralix CX23880-20MG rac-GR24 (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one 76974-79-3 298.29 C17H14O5 >98% 20MG 15000 chiralix CX23880-100MG rac-GR24 (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one 76974-79-3 298.29 C17H14O5 >98% 100MG 35000 chiralix CX38605-1G Fmoc-L-allysineethyleneacetal (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid Notavailable 411.45 C23H25NO6 Fmoc-Aea-OH >97% 1G 7200 chiralix CX38605-2G Fmoc-L-allysineethyleneacetal (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid Notavailable 411.45 C23H25NO6 Fmoc-Aea-OH >97% 2G 12400 chiralix CX59650-1G Fmoc-L-azidohomoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoicacid 942518-20-9 366.37 C19H18N4O4 Fmoc-Azh-OH >98% 1G 3400 chiralix CX59650-5G Fmoc-L-azidohomoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoicacid 942518-20-9 366.37 C19H18N4O4 Fmoc-Azh-OH >98% 5G 12000 chiralix CX94894-200MG L-bishomopropargylglycine (S)-2-aminohept-6-ynoicacid 835627-45-7 141.17 C7H11NO2 H-Bpg-OH >98% 200MG 4400 chiralix CX94894-500MG L-bishomopropargylglycine (S)-2-aminohept-6-ynoicacid 835627-45-7 141.17 C7H11NO2 H-Bpg-OH >98% 500MG 9000 chiralix CX94894-1G L-bishomopropargylglycine (S)-2-aminohept-6-ynoicacid 835627-45-7 141.17 C7H11NO2 H-Bpg-OH >98% 1G 14600 chiralix CX13745-1G (R)-propargylglycinolhydrochloride (R)-2-aminopent-4-yn-1-olhydrochloride Notavailable 135.59 C5H10ClNO >98% 1G 8200 chiralix CX13745-2G (R)-propargylglycinolhydrochloride (R)-2-aminopent-4-yn-1-olhydrochloride Notavailable 135.59 C5H10ClNO >98% 2G 14000 chiralix CX78500-1G (R)-allylglycinolhydrochloride (R)-2-aminopent-4-en-1-olhydrochloride 926660-30-2 137.61 C5H12ClNO >98% 1G 7400 chiralix CX78500-2G (R)-allylglycinolhydrochloride (R)-2-aminopent-4-en-1-olhydrochloride 926660-30-2 137.61 C5H12ClNO >98% 2G 12800 chiralix CX69324-500MG bis(N-Boc)-2-deoxystreptamine tert-butyl(1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 189157-45-7 362.42 C16H30N2O7 bis-Boc-2-DOS >95% 500MG 6200 chiralix CX69324-1G bis(N-Boc)-2-deoxystreptamine tert-butyl(1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate 189157-45-7 362.42 C16H30N2O7 bis-Boc-2-DOS >95% 1G 10800 chiralix CX96388-1G Boc-L-allysineethyleneacetal (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid Notavailable 289.32 C13H23NO6 Boc-Aea-OH >98% 1G 6200 chiralix CX96388-2G Boc-L-allysineethyleneacetal (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid Notavailable 289.32 C13H23NO6 Boc-Aea-OH >98% 2G 10600 chiralix CX96388-5G Boc-L-allysineethyleneacetal (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid Notavailable 289.32 C13H23NO6 Boc-Aea-OH >98% 5G 19900 chiralix CX42388-1G Cbz-L-allysineethyleneacetal (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid 852822-01-6 323.34 C16H21NO6 Z-Aea-OH >98% 1G 6200 chiralix CX42388-2G Cbz-L-allysineethyleneacetal (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid 852822-01-6 323.34 C16H21NO6 Z-Aea-OH >98% 2G 10600 chiralix CX42388-5G Cbz-L-allysineethyleneacetal (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid 852822-01-6 323.34 C16H21NO6 Z-Aea-OH >98% 5G 19900 chiralix CX44656-500MG Boc-L-homopropargylglycine (S)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid 208522-16-1 227.26 C11H17NO4 Boc-Hpg-OH >98% 500MG 9800 chiralix CX44656-1G Boc-L-homopropargylglycine (S)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid 208522-16-1 227.26 C11H17NO4 Boc-Hpg-OH >98% 1G 16000 chiralix CX69013-500MG Cbz-L-homopropargylglycine (S)-2-(benzyloxycarbonylamino)hex-5-ynoicacid Notavailable 261.27 C14H15NO4 Z-Hpg-OH >98% 500MG 9800 chiralix CX69013-1G Cbz-L-homopropargylglycine (S)-2-(benzyloxycarbonylamino)hex-5-ynoicacid Notavailable 261.27 C14H15NO4 Z-Hpg-OH >98% 1G 16000 chiralix CX54783-500MG Boc-D-homopropargylglycine (R)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid Notavailable 227.26 C11H17NO4 Boc-D-Hpg-OH >98% 500MG 9800 chiralix CX54783-1G Boc-D-homopropargylglycine (R)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid Notavailable 227.26 C11H17NO4 Boc-D-Hpg-OH >98% 1G 16000 chiralix CX14845-500MG Cbz-D-homopropargylglycine (R)-2-(benzyloxycarbonylamino)hex-5-ynoicacid Notavailable 261.27 C14H15NO4 Z-D-Hpg-OH >98% 500MG 9800 chiralix CX14845-1G Cbz-D-homopropargylglycine (R)-2-(benzyloxycarbonylamino)hex-5-ynoicacid Notavailable 261.27 C14H15NO4 Z-D-Hpg-OH >98% 1G 16000 chiralix CX87818-500MG Fmoc-D-homopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid Notavailable 349.38 C21H19NO4 Fmoc-D-Hpg-OH >97% 500MG 11200 chiralix CX87818-1G Fmoc-D-homopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid Notavailable 349.38 C21H19NO4 Fmoc-D-Hpg-OH >97% 1G 18400 chiralix CX57816-500MG Fmoc-L-bishomopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid Notavailable 363.41 C22H21NO4 Fmoc-Bpg-OH >97% 500MG 10400 chiralix CX57816-1G Fmoc-L-bishomopropargylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid Notavailable 363.41 C22H21NO4 Fmoc-Bpg-OH >97% 1G 16800 chiralix CX32424-200MG D-bishomopropargylglycine (R)-2-aminohept-6-ynoicacid 211054-03-4 141.17 C7H11NO2 H-D-Bpg-OH >98% 200MG 4400 chiralix CX32424-500MG D-bishomopropargylglycine (R)-2-aminohept-6-ynoicacid 211054-03-4 141.17 C7H11NO2 H-D-Bpg-OH >98% 500MG 9000 chiralix CX32424-1G D-bishomopropargylglycine (R)-2-aminohept-6-ynoicacid 211054-03-4 141.17 C7H11NO2 H-D-Bpg-OH >98% 1G 14600 chiralix CX80846-500MG Fmoc-D-bishomopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid Notavailable 363.41 C22H21NO4 Fmoc-D-Bpg-OH >97% 500MG 10400 chiralix CX80846-1G Fmoc-D-bishomopropargylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid Notavailable 363.41 C22H21NO4 Fmoc-D-Bpg-OH >97% 1G 16800 chiralix CX52977-1G (S)-Boc-beta3-phenylalanine (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid 103365-47-5 265.30 C14H19NO4 >98% 1G 2200 chiralix CX52977-2G (S)-Boc-beta3-phenylalanine (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid 103365-47-5 265.30 C14H19NO4 >98% 2G 3800 chiralix CX52977-5G (S)-Boc-beta3-phenylalanine (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid 103365-47-5 265.30 C14H19NO4 >98% 5G 7200 chiralix CX79659-1G (S)-Cbz-beta3-phenylalanine (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid 14441-08-8 299.32 C17H17NO4 >98% 1G 2200 chiralix CX79659-2G (S)-Cbz-beta3-phenylalanine (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid 14441-08-8 299.32 C17H17NO4 >98% 2G 3800 chiralix CX79659-5G (S)-Cbz-beta3-phenylalanine (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid 14441-08-8 299.32 C17H17NO4 >98% 5G 7200 chiralix CX56872-1G (S)-Fmoc-beta3-phenylalanine (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid 209252-15-3 387.43 C24H21NO4 >98% 1G 2600 chiralix CX56872-2G (S)-Fmoc-beta3-phenylalanine (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid 209252-15-3 387.43 C24H21NO4 >98% 2G 4400 chiralix CX56872-5G (S)-Fmoc-beta3-phenylalanine (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid 209252-15-3 387.43 C24H21NO4 >98% 5G 8600 chiralix CX44048-1G Boc-D-tert-leucine (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid 124655-17-0 231.29 C11H21NO4 Boc-D-tert-Leu-OH >98% 1G 2200 chiralix CX44048-2G Boc-D-tert-leucine (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid 124655-17-0 231.29 C11H21NO4 Boc-D-tert-Leu-OH >98% 2G 3800 chiralix CX44048-5G Boc-D-tert-leucine (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid 124655-17-0 231.29 C11H21NO4 Boc-D-tert-Leu-OH >98% 5G 7200 chiralix CX22855-1G Fmoc-D-tert-leucine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid 198543-64-5 353.41 C21H23NO4 Fmoc-D-tert-Leu-OH >97% 1G 2600 chiralix CX22855-2G Fmoc-D-tert-leucine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid 198543-64-5 353.41 C21H23NO4 Fmoc-D-tert-Leu-OH >97% 2G 4400 chiralix CX22855-5G Fmoc-D-tert-leucine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid 198543-64-5 353.41 C21H23NO4 Fmoc-D-tert-Leu-OH >97% 5G 8600 chiralix CX28901-1G (S)-Boc-alpha-methyl-phenylglycine (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoicacid 802541-88-4 265.30 C14H19NO4 (S)-Boc-Mpg-OH >98% 1G 9000 chiralix CX28901-2G (S)-Boc-alpha-methyl-phenylglycine (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoicacid 802541-88-4 265.30 C14H19NO4 (S)-Boc-Mpg-OH >98% 2G 14800 chiralix CX28344-1G (S)-Fmoc-alpha-methyl-phenylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid 881921-11-5 387.43 C24H21NO4 (S)-Fmoc-Mpg-OH >98% 1G 10400 chiralix CX28344-2G (S)-Fmoc-alpha-methyl-phenylglycine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid 881921-11-5 387.43 C24H21NO4 (S)-Fmoc-Mpg-OH >98% 2G 17200 chiralix CX93005-1G Fmoc-L-azidoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoicacid 684270-46-0 352.34 C18H16N4O4 Fmoc-Aza-OH >98% 1G 3400 chiralix CX93005-5G Fmoc-L-azidoalanine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoicacid 684270-46-0 352.34 C18H16N4O4 Fmoc-Aza-OH >98% 5G 12000 chiralix CX90286-200MG bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine 4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate 90852-19-0 340.29 C12H16N6O6 2-DOSdiazidetriacetate >98% 200MG 4200 chiralix CX90286-500MG bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine 4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate 90852-19-0 340.29 C12H16N6O6 2-DOSdiazidetriacetate >98% 500MG 8800 chiralix CX90286-1G bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine 4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate 90852-19-0 340.29 C12H16N6O6 2-DOSdiazidetriacetate >98% 1G 15200 chiralix CX44848-200MG (R)-4-oxopipecolicacidethyleneacetal (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid Notavailable 187.19 C8H13NO4 >98% 200MG 5200 chiralix CX44848-500MG (R)-4-oxopipecolicacidethyleneacetal (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid Notavailable 187.19 C8H13NO4 >98% 500MG 11000 chiralix CX44848-1G (R)-4-oxopipecolicacidethyleneacetal (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid Notavailable 187.19 C8H13NO4 >98% 1G 19200 chiralix CX45124-500MG (R)-alpha-methyl-phenylglycine (R)-2-amino-2-phenylpropanoicacid 29738-09-8 165.19 C9H11NO2 (R)-H-Mpg-OH >98% 500MG 6200 chiralix CX45124-1G (R)-alpha-methyl-phenylglycine (R)-2-amino-2-phenylpropanoicacid 29738-09-8 165.19 C9H11NO2 (R)-H-Mpg-OH >98% 1G 10400 chiralix CX45124-2G (R)-alpha-methyl-phenylglycine (R)-2-amino-2-phenylpropanoicacid 29738-09-8 165.19 C9H11NO2 (R)-H-Mpg-OH >98% 2G 17200 chiralix CX43844-1G L-azidoleucineCHAsalt cyclohexanaminium(S)-2-azido-4-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-Leu-OH·CHA >98% 1G 2800 chiralix CX43844-5G L-azidoleucineCHAsalt cyclohexanaminium(S)-2-azido-4-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-Leu-OH·CHA >98% 5G 10600 chiralix CX66793-1G L-azidovalineCHAsalt cyclohexanaminium(S)-2-azido-3-methylbutanoate Notavailable 242.32 C11H22N4O2 N3-Val-OH·CHA >98% 1G 2600 chiralix CX66793-5G L-azidovalineCHAsalt cyclohexanaminium(S)-2-azido-3-methylbutanoate Notavailable 242.32 C11H22N4O2 N3-Val-OH·CHA >98% 5G 9800 chiralix CX90285-1G L-azidotryptophanCHAsalt cyclohexanaminium(S)-2-azido-3-(1H-indol-2-yl)propanoate Notavailable 329.40 C17H23N5O2 N3-Trp-OH·CHA >98% 1G 2400 chiralix CX90285-5G L-azidotryptophanCHAsalt cyclohexanaminium(S)-2-azido-3-(1H-indol-2-yl)propanoate Notavailable 329.40 C17H23N5O2 N3-Trp-OH·CHA >98% 5G 9000 chiralix CX32182-1G L-azidoalanineCHAsalt cyclohexanaminium(S)-2-azidopropanoate Notavailable 214.26 C9H18N4O2 N3-Ala-OH·CHA >98% 1G 2800 chiralix CX32182-5G L-azidoalanineCHAsalt cyclohexanaminium(S)-2-azidopropanoate Notavailable 214.26 C9H18N4O2 N3-Ala-OH·CHA >98% 5G 10600 chiralix CX33085-1G L-azidophenylalanineCHAsalt cyclohexanaminium(S)-2-azido-3-phenylpropanoate Notavailable 290.36 C15H22N4O2 N3-Phe-OH·CHA >98% 1G 2400 chiralix CX33085-5G L-azidophenylalanineCHAsalt cyclohexanaminium(S)-2-azido-3-phenylpropanoate Notavailable 290.36 C15H22N4O2 N3-Phe-OH·CHA >98% 5G 9000 chiralix CX37236-1G L-azidoisoleucineCHAsalt cyclohexanaminium(2S,3S)-2-azido-3-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-Ile-OH·CHA >98% 1G 2800 chiralix CX37236-5G L-azidoisoleucineCHAsalt cyclohexanaminium(2S,3S)-2-azido-3-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-Ile-OH·CHA >98% 5G 10600 chiralix CX81236-1G L-azidotyrosineCHAsalt cyclohexanaminium(S)-2-azido-3-(4-hydroxyphenyl)propanoate Notavailable 306.36 C15H22N4O3 N3-Tyr-OH·CHA >97% 1G 2800 chiralix CX81236-5G L-azidotyrosineCHAsalt cyclohexanaminium(S)-2-azido-3-(4-hydroxyphenyl)propanoate Notavailable 306.36 C15H22N4O3 N3-Tyr-OH·CHA >97% 5G 10600 chiralix CX84940-1G L-azidomethionineCHAsalt cyclohexanaminium(S)-2-azido-4-(methylthio)butanoate Notavailable 274.38 C11H22N4O2S N3-Met-OH·CHA >98% 1G 2600 chiralix CX84940-5G L-azidomethionineCHAsalt cyclohexanaminium(S)-2-azido-4-(methylthio)butanoate Notavailable 274.38 C11H22N4O2S N3-Met-OH·CHA >98% 5G 9800 chiralix CX81456-200MG (S)-5-oxopipecolicacidethyleneacetal (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid Notavailable 187.19 C8H13NO4 >98% 200MG 5200 chiralix CX81456-500MG (S)-5-oxopipecolicacidethyleneacetal (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid Notavailable 187.19 C8H13NO4 >98% 500MG 11000 chiralix CX81456-1G (S)-5-oxopipecolicacidethyleneacetal (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid Notavailable 187.19 C8H13NO4 >98% 1G 19200 chiralix CX80632-1G L-azidothreoninetert-butyletherCHAsalt cyclohexanaminium(2S,3R)-2-azido-3-tert-butoxybutanoate Notavailable 300.40 C14H28N4O3 N3-Thr(OtBu)-OH·CHA >98% 1G 2800 chiralix CX80632-5G L-azidothreoninetert-butyletherCHAsalt cyclohexanaminium(2S,3R)-2-azido-3-tert-butoxybutanoate Notavailable 300.40 C14H28N4O3 N3-Thr(OtBu)-OH·CHA >98% 5G 10600 chiralix CX59871-1G L-azidoserineCHAsalt cyclohexanaminium(S)-2-azido-3-hydroxypropanoate Notavailable 230.26 C9H18N4O3 N3-Ser-OH·CHA >98% 1G 2600 chiralix CX59871-5G L-azidoserineCHAsalt cyclohexanaminium(S)-2-azido-3-hydroxypropanoate Notavailable 230.26 C9H18N4O3 N3-Ser-OH·CHA >98% 5G 9800 chiralix CX20625-1G L-azidoasparticacidmono-tert-butylesterCHAsalt cyclohexanaminium(S)-2-azido-4-tert-butoxy-4-oxobutanoate Notavailable 314.38 C14H26N4O4 N3-Asp(OtBu)-OH·CHA >98% 1G 2600 chiralix CX20625-5G L-azidoasparticacidmono-tert-butylesterCHAsalt cyclohexanaminium(S)-2-azido-4-tert-butoxy-4-oxobutanoate Notavailable 314.38 C14H26N4O4 N3-Asp(OtBu)-OH·CHA >98% 5G 9800 chiralix CX24163-1G L-azidoglutamicacidmono-tert-butylesterCHAsalt cyclohexanaminium(S)-2-azido-5-tert-butoxy-5-oxopentanoate Notavailable 328.41 C15H28N4O4 N3-Glu(OtBu)-OH·CHA >98% 1G 2800 chiralix CX24163-5G L-azidoglutamicacidmono-tert-butylesterCHAsalt cyclohexanaminium(S)-2-azido-5-tert-butoxy-5-oxopentanoate Notavailable 328.41 C15H28N4O4 N3-Glu(OtBu)-OH·CHA >98% 5G 10600 chiralix CX68680-1G L-azidotyrosinetert-butyletherCHAsalt cyclohexanaminium(S)-2-azido-3-(4-tert-butoxyphenyl)propanoate Notavailable 362.47 C19H30N4O3 N3-Tyr(OtBu)-OH·CHA >98% 1G 2800 chiralix CX68680-5G L-azidotyrosinetert-butyletherCHAsalt cyclohexanaminium(S)-2-azido-3-(4-tert-butoxyphenyl)propanoate Notavailable 362.47 C19H30N4O3 N3-Tyr(OtBu)-OH·CHA >98% 5G 10600 chiralix CX55921-1G L-azidoserinetert-butyletherCHAsalt cyclohexanaminium(S)-2-azido-3-tert-butoxypropanoate Notavailable 286.37 C13H26N4O3 N3-Ser(OtBu)-OH·CHA >98% 1G 2800 chiralix CX55921-5G L-azidoserinetert-butyletherCHAsalt cyclohexanaminium(S)-2-azido-3-tert-butoxypropanoate Notavailable 286.37 C13H26N4O3 N3-Ser(OtBu)-OH·CHA >98% 5G 10600 chiralix CX54776-200MG (S)-4-oxopipecolicacidethyleneacetal (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid 356073-54-6 187.19 C8H13NO4 >98% 200MG 5200 chiralix CX54776-500MG (S)-4-oxopipecolicacidethyleneacetal (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid 356073-54-6 187.19 C8H13NO4 >98% 500MG 11000 chiralix CX54776-1G (S)-4-oxopipecolicacidethyleneacetal (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid 356073-54-6 187.19 C8H13NO4 >98% 1G 19200 chiralix CX46058-1G D-azidovalineCHAsalt cyclohexanaminium(R)-2-azido-3-methylbutanoate Notavailable 242.32 C11H22N4O2 N3-D-Val-OH·CHA >98% 1G 3000 chiralix CX46058-5G D-azidovalineCHAsalt cyclohexanaminium(R)-2-azido-3-methylbutanoate Notavailable 242.32 C11H22N4O2 N3-D-Val-OH·CHA >98% 5G 11200 chiralix CX44158-1G D-azidoalanineCHAsalt cyclohexanaminium(R)-2-azidopropanoate Notavailable 214.26 C9H18N4O2 N3-D-Ala-OH·CHA >98% 1G 3400 chiralix CX44158-5G D-azidoalanineCHAsalt cyclohexanaminium(R)-2-azidopropanoate Notavailable 214.26 C9H18N4O2 N3-D-Ala-OH·CHA >98% 5G 12800 chiralix CX27954-1G D-azidophenylalanineCHAsalt cyclohexanaminium(R)-2-azido-3-phenylpropanoate Notavailable 290.36 C15H22N4O2 D-N3-Phe-OH·CHA >98% 1G 2800 chiralix CX27954-5G D-azidophenylalanineCHAsalt cyclohexanaminium(R)-2-azido-3-phenylpropanoate Notavailable 290.36 C15H22N4O2 D-N3-Phe-OH·CHA >98% 5G 10600 chiralix CX56656-1G D-azidomethionineCHAsalt cyclohexanaminium(R)-2-azido-4-(methylthio)butanoate Notavailable 274.38 C11H22N4O2S N3-D-Met-OH·CHA >98% 1G 2800 chiralix CX56656-5G D-azidomethionineCHAsalt cyclohexanaminium(R)-2-azido-4-(methylthio)butanoate Notavailable 274.38 C11H22N4O2S N3-D-Met-OH·CHA >98% 5G 10600 chiralix CX16129-500MG Cbz-L-bishomopropargylglycineCHAsalt cyclohexanaminium(S)-2-(benzyloxycarbonylamino)hept-6-ynoate Notavailable 374.47 C21H30N2O4 Z-Bpg-OH·CHA >98% 500MG 9000 chiralix CX16129-1G Cbz-L-bishomopropargylglycineCHAsalt cyclohexanaminium(S)-2-(benzyloxycarbonylamino)hept-6-ynoate Notavailable 374.47 C21H30N2O4 Z-Bpg-OH·CHA >98% 1G 14600 chiralix CX65817-1G (S)-Cbz-alpha-methyl-phenylglycineCHAsalt cyclohexanaminium(S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate Notavailable 398.50 C23H30N2O4 (S)-Cbz-Mpg-OH·CHA >98% 1G 9000 chiralix CX65817-2G (S)-Cbz-alpha-methyl-phenylglycineCHAsalt cyclohexanaminium(S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate Notavailable 398.50 C23H30N2O4 (S)-Cbz-Mpg-OH·CHA >98% 2G 14800 chiralix CX19691-500MG Boc-D-bishomopropargylglycineCHAsalt cyclohexanaminium(R)-2-(tert-butoxycarbonylamino)hept-6-ynoate Notavailable 340.46 C18H32N2O4 Boc-D-Bpg-OH·CHA >98% 500MG 9000 chiralix CX19691-1G Boc-D-bishomopropargylglycineCHAsalt cyclohexanaminium(R)-2-(tert-butoxycarbonylamino)hept-6-ynoate Notavailable 340.46 C18H32N2O4 Boc-D-Bpg-OH·CHA >98% 1G 14600 chiralix CX59796-500MG Boc-L-bishomopropargylglycineCHAsalt cyclohexanaminium(S)-2-(tert-butoxycarbonylamino)hept-6-ynoate Notavailable 340.46 C18H32N2O4 Boc-Bpg-OH·CHA >98% 500MG 9000 chiralix CX59796-1G Boc-L-bishomopropargylglycineCHAsalt cyclohexanaminium(S)-2-(tert-butoxycarbonylamino)hept-6-ynoate Notavailable 340.46 C18H32N2O4 Boc-Bpg-OH·CHA >98% 1G 14600 chiralix CX79723-1G (R)-Fmoc-alpha-methyl-phenylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid 881920-86-1 387.43 C24H21NO4 (R)-Fmoc-Mpg-OH >98% 1G 12000 chiralix CX79723-2G (R)-Fmoc-alpha-methyl-phenylglycine (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid 881920-86-1 387.43 C24H21NO4 (R)-Fmoc-Mpg-OH >98% 2G 19800 chiralix CX32015-1G Cbz-D-tert-leucineCHAsalt cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate Notavailable 364.48 C20H32N2O4 Z-D-tert-Leu-OH·CHA >98% 1G 2200 chiralix CX32015-2G Cbz-D-tert-leucineCHAsalt cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate Notavailable 364.48 C20H32N2O4 Z-D-tert-Leu-OH·CHA >98% 2G 3800 chiralix CX32015-5G Cbz-D-tert-leucineCHAsalt cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate Notavailable 364.48 C20H32N2O4 Z-D-tert-Leu-OH·CHA >98% 5G 7200 chiralix CX81118-1G Fmoc-L-azidolysine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoicacid 159610-89-6 394.42 C21H22N4O4 Fmoc-Lys(N2)-OH >98% 1G 3400 chiralix CX81118-5G Fmoc-L-azidolysine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoicacid 159610-89-6 394.42 C21H22N4O4 Fmoc-Lys(N2)-OH >98% 5G 12000 chiralix CX19587-500MG Cbz-D-bishomopropargylglycineCHAsalt cyclohexanaminium(R)-2-(benzyloxycarbonylamino)hept-6-ynoate Notavailable 374.47 C21H30N2O4 Z-D-Bpg-OH·CHA >98% 500MG 9000 chiralix CX19587-1G Cbz-D-bishomopropargylglycineCHAsalt cyclohexanaminium(R)-2-(benzyloxycarbonylamino)hept-6-ynoate Notavailable 374.47 C21H30N2O4 Z-D-Bpg-OH·CHA >98% 1G 14600 chiralix CX28021-500MG H-Arg(Boc)2-pNA (S,E)-tert-butyl(4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate Notavailable 494.54 C22H34N6O7 >97% 500MG 6000 chiralix CX28021-1G H-Arg(Boc)2-pNA (S,E)-tert-butyl(4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate Notavailable 494.54 C22H34N6O7 >97% 1G 11000 chiralix CX72798-1G D-azidoasparticacidmono-tert-butylesterCHAsalt cyclohexanaminium(R)-2-azido-4-tert-butoxy-4-oxobutanoate Notavailable 314.38 C14H26N4O4 N3-D-Asp(OtBu)-OH·CHA >98% 1G 6200 chiralix CX72798-5G D-azidoasparticacidmono-tert-butylesterCHAsalt cyclohexanaminium(R)-2-azido-4-tert-butoxy-4-oxobutanoate Notavailable 314.38 C14H26N4O4 N3-D-Asp(OtBu)-OH·CHA >98% 5G 23400 chiralix CX93516-1G D-azidoglutamicacidmono-tert-butylesterCHAsalt cyclohexanaminium(R)-2-azido-5-tert-butoxy-5-oxopentanoate Notavailable 328.41 C15H28N4O4 N3-D-Glu(OtBu)-OH·CHA >98% 1G 5200 chiralix CX93516-5G D-azidoglutamicacidmono-tert-butylesterCHAsalt cyclohexanaminium(R)-2-azido-5-tert-butoxy-5-oxopentanoate Notavailable 328.41 C15H28N4O4 N3-D-Glu(OtBu)-OH·CHA >98% 5G 19600 chiralix CX76762-1G D-azidoleucineCHAsalt cyclohexanaminium(R)-2-azido-4-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-D-Leu-OH·CHA >98% 1G 3000 chiralix CX76762-5G D-azidoleucineCHAsalt cyclohexanaminium(R)-2-azido-4-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-D-Leu-OH·CHA >98% 5G 11200 chiralix CX53333-1G D-azidoisoleucineCHAsalt cyclohexanaminium(2R,3R)-2-azido-3-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-D-Ile-OH·CHA >98% 1G 9200 chiralix CX53333-2G D-azidoisoleucineCHAsalt cyclohexanaminium(2R,3R)-2-azido-3-methylpentanoate Notavailable 256.34 C12H24N4O2 N3-D-Ile-OH·CHA >98% 2G 16400 chiralix CX83245-1G D-azidotyrosinetert-butyletherCHAsalt cyclohexanaminium(R)-2-azido-3-(4-tert-butoxyphenyl)propanoate Notavailable 362.47 C19H30N4O3 N3-D-Tyr(OtBu)-OH·CHA >98% 1G 5400 chiralix CX83245-5G D-azidotyrosinetert-butyletherCHAsalt cyclohexanaminium(R)-2-azido-3-(4-tert-butoxyphenyl)propanoate Notavailable 362.47 C19H30N4O3 N3-D-Tyr(OtBu)-OH·CHA >98% 5G 20400 chiralix CX13425-1G D-azidoserinetert-butyletherCHAsalt cyclohexanaminium(R)-2-azido-3-tert-butoxypropanoate Notavailable 286.37 C13H26N4O3 N3-D-Ser(OtBu)-OH·CHA >98% 1G 7200 chiralix CX13425-5G D-azidoserinetert-butyletherCHAsalt cyclohexanaminium(R)-2-azido-3-tert-butoxypropanoate Notavailable 286.37 C13H26N4O3 N3-D-Ser(OtBu)-OH·CHA >98% 5G 27200 chiralix CX29937-1G D-azidothreoninetert-butyletherCHAsalt cyclohexanaminium(2R,3S)-2-azido-3-tert-butoxybutanoate Notavailable 300.40 C14H28N4O3 N3-D-Thr(OtBu)-OH·CHA >98% 1G 6400 chiralix CX29937-5G D-azidothreoninetert-butyletherCHAsalt cyclohexanaminium(2R,3S)-2-azido-3-tert-butoxybutanoate Notavailable 300.40 C14H28N4O3 N3-D-Thr(OtBu)-OH·CHA >98% 5G 24200 chiralix CX85233-1G L-azidothreonineCHAsalt cyclohexanaminium(2S,3R)-2-azido-3-hydroxybutanoate Notavailable 244.29 C10H20N4O3 N3-Thr-OH·CHA >98% 1G 2600 chiralix CX85233-5G L-azidothreonineCHAsalt cyclohexanaminium(2S,3R)-2-azido-3-hydroxybutanoate Notavailable 244.29 C10H20N4O3 N3-Thr-OH·CHA >98% 5G 9800 chiralix CX37313-1G D-azidothreonineCHAsalt cyclohexanaminium(2R,3S)-2-azido-3-hydroxybutanoate Notavailable 244.29 C10H20N4O3 N3-D-Thr-OH·CHA >98% 1G 3000 chiralix CX37313-5G D-azidothreonineCHAsalt cyclohexanaminium(2R,3S)-2-azido-3-hydroxybutanoate Notavailable 244.29 C10H20N4O3 N3-D-Thr-OH·CHA >98% 5G 11200 chiralix CX95405-1G D-azidoserineCHAsalt cyclohexanaminium(R)-2-azido-3-hydroxypropanoate Notavailable 230.26 C9H18N4O3 N3-D-Ser-OH·CHA >98% 1G 3200 chiralix CX95405-5G D-azidoserineCHAsalt cyclohexanaminium(R)-2-azido-3-hydroxypropanoate Notavailable 230.26 C9H18N4O3 N3-D-Ser-OH·CHA >98% 5G 12000 chiralix CX57717-1G L-azidoglutamineDCHAsalt dicyclohexylammonium(S)-5-amino-2-azido-5-oxopentanoate Notavailable 353.46 C17H31N5O3 N3-Gln-OH·DCHA >98% 1G 2600 chiralix CX57717-5G L-azidoglutamineDCHAsalt dicyclohexylammonium(S)-5-amino-2-azido-5-oxopentanoate Notavailable 353.46 C17H31N5O3 N3-Gln-OH·DCHA >98% 5G 9800 chiralix CX79807-1G D-azidoglutamineDCHAsalt dicyclohexylammonium(R)-5-amino-2-azido-5-oxopentanoate Notavailable 353.46 C17H31N5O3 N3-D-Gln-OH·DCHA >98% 1G 3200 chiralix CX79807-5G D-azidoglutamineDCHAsalt dicyclohexylammonium(R)-5-amino-2-azido-5-oxopentanoate Notavailable 353.46 C17H31N5O3 N3-D-Gln-OH·DCHA >98% 5G 12000 chiralix CX94556-1G L-azidoasparagineDCHAsalt dicyclohexylammonium(S)-4-amino-2-azido-4-oxobutanoate 79410-49-4 339.43 C16H29N5O3 N3-Asn-OH·DCHA >98% 1G 3200 chiralix CX94556-5G L-azidoasparagineDCHAsalt dicyclohexylammonium(S)-4-amino-2-azido-4-oxobutanoate 79410-49-4 339.43 C16H29N5O3 N3-Asn-OH·DCHA >98% 5G 12000 chiralix CX83100-1G D-azidoasparagineDCHAsalt dicyclohexylammonium(R)-4-amino-2-azido-4-oxobutanoate Notavailable 339.43 C16H29N5O3 N3-D-Asn-OH·DCHA >98% 1G 4000 chiralix CX83100-5G D-azidoasparagineDCHAsalt dicyclohexylammonium(R)-4-amino-2-azido-4-oxobutanoate Notavailable 339.43 C16H29N5O3 N3-D-Asn-OH·DCHA >98% 5G 15000 chiralix CX48141-1G D-azidotryptophanCHAsalt cyclohexanaminium(R)-2-azido-3-(1H-indol-2-yl)propanoate Notavailable 329.40 C17H23N5O2 N3-D-Trp-OH·CHA >98% 1G 2600 chiralix CX48141-5G D-azidotryptophanCHAsalt cyclohexanaminium(R)-2-azido-3-(1H-indol-2-yl)propanoate Notavailable 329.40 C17H23N5O2 N3-D-Trp-OH·CHA >98% 5G 9800 chiralix CX93426-1G N-im-trityl-L-azidohistidineCHAsalt cyclohexanaminium(S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate Notavailable 522.64 C31H34N6O2 N3-His(Trt)-OH·CHA >98% 1G 4000 chiralix CX93426-5G N-im-trityl-L-azidohistidineCHAsalt cyclohexanaminium(S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate Notavailable 522.64 C31H34N6O2 N3-His(Trt)-OH·CHA >98% 5G 15000 chiralix CX24279-1G D-azidotyrosineCHAsalt cyclohexanaminium(R)-2-azido-3-(4-hydroxyphenyl)propanoate Notavailable 306.36 C15H22N4O3 N3-D-Tyr-OH·CHA >98% 1G 3600 chiralix CX24279-5G D-azidotyrosineCHAsalt cyclohexanaminium(R)-2-azido-3-(4-hydroxyphenyl)propanoate Notavailable 306.36 C15H22N4O3 N3-D-Tyr-OH·CHA >98% 5G 13600 chiralix CX78063-1G L-azido-tert-leucineCHAsalt cyclohexanaminium(S)-2-azido-3,3-dimethylbutanoate Notavailable 256.34 C12H24N4O2 N3-tert-Leu-OH·CHA >98% 1G 2800 chiralix CX78063-5G L-azido-tert-leucineCHAsalt cyclohexanaminium(S)-2-azido-3,3-dimethylbutanoate Notavailable 256.34 C12H24N4O2 N3-tert-Leu-OH·CHA >98% 5G 10600 chiralix CX30547-1G D-azido-tert-leucineCHAsalt cyclohexanaminium(R)-2-azido-3,3-dimethylbutanoate Notavailable 256.34 C12H24N4O2 N3-D-tert-Leu-OH·CHA >98% 1G 6600 chiralix CX30547-5G D-azido-tert-leucineCHAsalt cyclohexanaminium(R)-2-azido-3,3-dimethylbutanoate Notavailable 256.34 C12H24N4O2 N3-D-tert-Leu-OH·CHA >98% 5G 25000 chiralix CX78942-1G L-azidoallylglycineCHAsalt cyclohexanaminium(S)-2-azidopent-4-enoate Notavailable 240.30 C11H20N4O2 N3-Alg-OH·CHA >98% 1G 5600 chiralix CX78942-5G L-azidoallylglycineCHAsalt cyclohexanaminium(S)-2-azidopent-4-enoate Notavailable 240.30 C11H20N4O2 N3-Alg-OH·CHA >98% 5G 21200 chiralix CX61332-1G D-azidoallylglycineCHAsalt cyclohexanaminium(R)-2-azidopent-4-enoate Notavailable 240.30 C11H20N4O2 N3-D-Alg-OH·CHA >98% 1G 9000 chiralix CX61332-2G D-azidoallylglycineCHAsalt cyclohexanaminium(R)-2-azidopent-4-enoate Notavailable 240.30 C11H20N4O2 N3-D-Alg-OH·CHA >98% 2G 16000 chiralix CX56925-1G Ng-Pmc-L-azidoarginine (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoicacid Notavailable 466.55 C20H30N6O5S Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine >95% 1G 4000 chiralix CX56925-5G Ng-Pmc-L-azidoarginine (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoicacid Notavailable 466.55 C20H30N6O5S Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine >95% 5G 15000 chiralix CX22361-1G (S)-azido-alpha-methyl-phenylglycineCHAsalt cyclohexanaminium(S)-2-azido-2-phenylpropanoate Notavailable 290.36 C15H22N4O2 (S)-N3-Mpg-OH·CHA >98% 1G 9000 chiralix CX22361-2G (S)-azido-alpha-methyl-phenylglycineCHAsalt cyclohexanaminium(S)-2-azido-2-phenylpropanoate Notavailable 290.36 C15H22N4O2 (S)-N3-Mpg-OH·CHA >98% 2G 14800 chiralix CX52265-1G (R)-azido-alpha-methylphenylglycineCHAsalt cyclohexanaminium(R)-2-azido-2-phenylpropanoate Notavailable 290.36 C15H22N4O2 (R)-N3-Mpg-OH·CHA >98% 1G 10400 chiralix CX52265-2G (R)-azido-alpha-methylphenylglycineCHAsalt cyclohexanaminium(R)-2-azido-2-phenylpropanoate Notavailable 290.36 C15H22N4O2 (R)-N3-Mpg-OH·CHA >98% 2G 17200 chiralix CX71813-1G S-Trityl-L-azidocysteineCHAsalt cyclohexanaminium(R)-2-azido-3-(tritylthio)propanoate Notavailable 488.64 C28H32N4O2S N3-Cys(Trt)-OH·CHA >98% 1G 3000 chiralix CX71813-5G S-Trityl-L-azidocysteineCHAsalt cyclohexanaminium(R)-2-azido-3-(tritylthio)propanoate Notavailable 488.64 C28H32N4O2S N3-Cys(Trt)-OH·CHA >98% 5G 11200 chiralix CX40608-5G 6-azidohexanoicacid 6-azidohexanoicacid 79598-53-1 157.17 C6H11N3O2 >98% 5G 6000 chiralix CX40608-10G 6-azidohexanoicacid 6-azidohexanoicacid 79598-53-1 157.17 C6H11N3O2 >98% 10G 11000 chiralix CX23053-500MG (S)-bishomopropargylglycinolhydrochloride (S)-2-aminohept-6-yn-1-olhydrochloride Notavailable 163.65 C7H14ClNO >98% 500MG 10400 chiralix CX23053-1G (S)-bishomopropargylglycinolhydrochloride (S)-2-aminohept-6-yn-1-olhydrochloride Notavailable 163.65 C7H14ClNO >98% 1G 17200 chiralix CX63523-500MG (R)-bishomopropargylglycinolhydrochloride (R)-2-aminohept-6-yn-1-olhydrochloride Notavailable 163.65 C7H14ClNO >98% 500MG 10400 chiralix CX63523-1G (R)-bishomopropargylglycinolhydrochloride (R)-2-aminohept-6-yn-1-olhydrochloride Notavailable 163.65 C7H14ClNO >98% 1G 17200 chiralix CX69091-500MG (R)-homopropargylglycinolhydrochloride (R)-2-aminohex-5-yn-1-olhydrochloride Notavailable 149.62 C6H12ClNO >98% 500MG 11000 chiralix CX69091-1G (R)-homopropargylglycinolhydrochloride (R)-2-aminohex-5-yn-1-olhydrochloride Notavailable 149.62 C6H12ClNO >98% 1G 17800 chiralix CX76358-500MG (S)-homopropargylglycinolhydrochloride (S)-2-aminohex-5-yn-1-olhydrochloride Notavailable 149.62 C6H12ClNO >98% 500MG 11000 chiralix CX76358-1G (S)-homopropargylglycinolhydrochloride (S)-2-aminohex-5-yn-1-olhydrochloride Notavailable 149.62 C6H12ClNO >98% 1G 17800 chiralix CX55029-2MG cereulide cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 Notavailable 1153.40 C57H96N6O18 >95% 2MG 12000 chiralix CX55029-5MG cereulide cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 Notavailable 1153.40 C57H96N6O18 >95% 5MG 24000 chiralix CX45120-1G H-Orn(Boc)-pNA (S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate Notavailable 352.39 C16H24N4O5 >98% 1G 4000 chiralix CX45120-2G H-Orn(Boc)-pNA (S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate Notavailable 352.39 C16H24N4O5 >98% 2G 9000 chiralix CX45120-5G H-Orn(Boc)-pNA (S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate Notavailable 352.39 C16H24N4O5 >98% 5G 15000 chiralix CX57163-2MG 13C6-cereulide cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 Notavailable 1159.36 C5113C6H96N6O18 >95% 2MG 24000 chiralix CX64158-1G Fmoc-Orn-pNA·HCl (S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride Notavailable 510.97 C26H27ClN4O5 Fmoc-Orn-pNAHClsalt >98% 1G 4000 chiralix CX64158-2G Fmoc-Orn-pNA·HCl (S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride Notavailable 510.97 C26H27ClN4O5 Fmoc-Orn-pNAHClsalt >98% 2G 7200 chiralix CX64158-5G Fmoc-Orn-pNA·HCl (S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride Notavailable 510.97 C26H27ClN4O5 Fmoc-Orn-pNAHClsalt >98% 5G 15000 chiralix CX80044-250MG Bis(H-Orn(Boc))-rhodamine110 Bis(H-Orn(Boc))-rhodamine Notavailable 758.86 C40H50N6O9 >95% 250MG 7600 chiralix CX80044-500MG Bis(H-Orn(Boc))-rhodamine110 Bis(H-Orn(Boc))-rhodamine Notavailable 758.86 C40H50N6O9 >95% 500MG 14000 chiralix CX80044-1G Bis(H-Orn(Boc))-rhodamine110 Bis(H-Orn(Boc))-rhodamine Notavailable 758.86 C40H50N6O9 >95% 1G 25000 chiralix CX67830-250MG Bis(H-Arg(Boc)2)-rhodamine110 Bis(H-Arg(Boc)2)-rhodamine Notavailable 1043.17 C52H70N10O13 >95% 250MG 7800 chiralix CX67830-500MG Bis(H-Arg(Boc)2)-rhodamine110 Bis(H-Arg(Boc)2)-rhodamine Notavailable 1043.17 C52H70N10O13 >95% 500MG 14400 chiralix CX67830-1G Bis(H-Arg(Boc)2)-rhodamine110 Bis(H-Arg(Boc)2)-rhodamine Notavailable 1043.17 C52H70N10O13 >95% 1G 26000 chiralix CX18326-1G Fmoc-Orn-AMC·HCl (S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride Notavailable 548.03 C30H30ClN3O5 >98% 1G 5000 chiralix CX18326-2G Fmoc-Orn-AMC·HCl (S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride Notavailable 548.03 C30H30ClN3O5 >98% 2G 9000 chiralix CX18326-5G Fmoc-Orn-AMC·HCl (S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride Notavailable 548.03 C30H30ClN3O5 >98% 5G 19000 chiralix CX59077-1G H-Orn(Boc)-AMC (S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate Notavailable 389.45 C20H27N3O5 >98% 1G 6000 chiralix CX59077-2G H-Orn(Boc)-AMC (S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate Notavailable 389.45 C20H27N3O5 >98% 2G 10800 chiralix CX59077-5G H-Orn(Boc)-AMC (S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate Notavailable 389.45 C20H27N3O5 >98% 5G 22000 chiralix CX48623-1G H-Lys(Boc)-AMC (S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate 222037-62-9 403.47 C21H29N3O5 >98% 1G 5000 chiralix CX48623-2G H-Lys(Boc)-AMC (S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate 222037-62-9 403.47 C21H29N3O5 >98% 2G 9000 chiralix CX48623-5G H-Lys(Boc)-AMC (S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate 222037-62-9 403.47 C21H29N3O5 >98% 5G 19000 chiralix CX55361-500MG H-Arg(Boc)2-AMC H-Arg(Boc)2-AMC Notavailable 531.60 C26H37N5O7 >97% 500MG 6000 chiralix CX55361-1G H-Arg(Boc)2-AMC H-Arg(Boc)2-AMC Notavailable 531.60 C26H37N5O7 >97% 1G 10800 chiralix CX84944-1G Fmoc-Lys-AMC·HCl (S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride Notavailable 562.06 C31H32ClN3O5 >98% 1G 4000 chiralix CX84944-2G Fmoc-Lys-AMC·HCl (S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride Notavailable 562.06 C31H32ClN3O5 >98% 2G 7200 chiralix CX84944-5G Fmoc-Lys-AMC·HCl (S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride Notavailable 562.06 C31H32ClN3O5 >98% 5G 15000 chiralix CX69359-5G 4-azidobutyricacid 4-azidobutanoicacid 54447-68-6 129.12 C4H7N3O2 gamma-azidobutyricacid >98% 5G 6000 chiralix CX69359-10G 4-azidobutyricacid 4-azidobutanoicacid 54447-68-6 129.12 C4H7N3O2 gamma-azidobutyricacid >98% 10G 11000 chiralix CX31309-5G 5-azidovalericacid 5-azidopentanoicacid 79583-98-5 143.14 C5H9N3O2 delta-azidovalericacid >98% 5G 6600 chiralix CX31309-10G 5-azidovalericacid 5-azidopentanoicacid 79583-98-5 143.14 C5H9N3O2 delta-azidovalericacid >98% 10G 11800 chiralix CX98490-5G 7-azidoheptanoicacid 7-azidoheptanoicacid 135920-28-4 171.20 C7H13N3O2 >98% 5G 6000 chiralix CX98490-10G 7-azidoheptanoicacid 7-azidoheptanoicacid 135920-28-4 171.20 C7H13N3O2 >98% 10G 11000 chiralix CX65527-1G 6-methylcyclohex-1-enecarboxylicacid 6-methylcyclohex-1-enecarboxylicacid 5726-56-7 140.18 C8H12O2 >98% 1G 2800 chiralix CX65527-5G 6-methylcyclohex-1-enecarboxylicacid 6-methylcyclohex-1-enecarboxylicacid 5726-56-7 140.18 C8H12O2 >98% 5G 10600 chiralix CX65527-10G 6-methylcyclohex-1-enecarboxylicacid 6-methylcyclohex-1-enecarboxylicacid 5726-56-7 140.18 C8H12O2 >98% 10G 17000 chiralix CX61074-200MG (S)-beta2-homoalanineHClsalt (S)-3-amino-2-methylpropanoicacidhydrochloride Notavailable 139.58 C4H10ClNO2 (S)-beta2-hAla-OH·HCl >98% 200MG 4800 chiralix CX61074-500MG (S)-beta2-homoalanineHClsalt (S)-3-amino-2-methylpropanoicacidhydrochloride Notavailable 139.58 C4H10ClNO2 (S)-beta2-hAla-OH·HCl >98% 500MG 9800 chiralix CX61074-1G (S)-beta2-homoalanineHClsalt (S)-3-amino-2-methylpropanoicacidhydrochloride Notavailable 139.58 C4H10ClNO2 (S)-beta2-hAla-OH·HCl >98% 1G 16000 chiralix CX39389-200MG (R)-beta2-homoalanineHClsalt (R)-3-amino-2-methylpropanoicacidhydrochloride Notavailable 139.58 C4H10ClNO2 (R)-beta2-hAla-OH·HCl >98% 200MG 4800 chiralix CX39389-500MG (R)-beta2-homoalanineHClsalt (R)-3-amino-2-methylpropanoicacidhydrochloride Notavailable 139.58 C4H10ClNO2 (R)-beta2-hAla-OH·HCl >98% 500MG 9800 chiralix CX39389-1G (R)-beta2-homoalanineHClsalt (R)-3-amino-2-methylpropanoicacidhydrochloride Notavailable 139.58 C4H10ClNO2 (R)-beta2-hAla-OH·HCl >98% 1G 16000 chiralix CX80391-200MG (R)-beta2-homoleucineHClsalt (R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride Notavailable 181.66 C7H16ClNO2 (R)-beta2-hLeu-OH·HCl >98% 200MG 4800 chiralix CX80391-500MG (R)-beta2-homoleucineHClsalt (R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride Notavailable 181.66 C7H16ClNO2 (R)-beta2-hLeu-OH·HCl >98% 500MG 9800 chiralix CX80391-1G (R)-beta2-homoleucineHClsalt (R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride Notavailable 181.66 C7H16ClNO2 (R)-beta2-hLeu-OH·HCl >98% 1G 16000 chiralix CX82876-200MG (R)-beta2-homovalineHClsalt (R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride Notavailable 167.63 C6H14ClNO2 (R)-beta2-hVal-OH·HCl >98% 200MG 4800 chiralix CX82876-500MG (R)-beta2-homovalineHClsalt (R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride Notavailable 167.63 C6H14ClNO2 (R)-beta2-hVal-OH·HCl >98% 500MG 9800 chiralix CX82876-1G (R)-beta2-homovalineHClsalt (R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride Notavailable 167.63 C6H14ClNO2 (R)-beta2-hVal-OH·HCl >98% 1G 16000 chiralix CX93488-1MG (±)-sorgolactone (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one Notavailable 316.35 C18H20O5 racemicsorgolactone >98% 1MG 4000 chiralix CX93488-5MG (±)-sorgolactone (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one Notavailable 316.35 C18H20O5 racemicsorgolactone >98% 5MG 15000 chiralix CX64382-1MG (±)-strigol (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one 51820-11-2 346.37 C19H22O6 >98% 1MG 5000 chiralix CX64382-5MG (±)-strigol (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one 51820-11-2 346.37 C19H22O6 >98% 5MG 18800 chiralix CX88057-10MG Nijmegen-1 (Z)-methyl2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate 159155-03-0 343.29 C17H13NO7 >98% 10MG 3600 chiralix CX88057-50MG Nijmegen-1 (Z)-methyl2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate 159155-03-0 343.29 C17H13NO7 >98% 50MG 11800 chiralix CX42450-200MG (S)-beta2-homophenylalanineHClsalt (S)-3-amino-2-benzylpropanoicacidhydrochloride 1010806-95-7 215.68 C10H14ClNO2 (S)-beta2-hPhe-OH·HCl >98% 200MG 4800 chiralix CX42450-500MG (S)-beta2-homophenylalanineHClsalt (S)-3-amino-2-benzylpropanoicacidhydrochloride 1010806-95-7 215.68 C10H14ClNO2 (S)-beta2-hPhe-OH·HCl >98% 500MG 9800 chiralix CX42450-1G (S)-beta2-homophenylalanineHClsalt (S)-3-amino-2-benzylpropanoicacidhydrochloride 1010806-95-7 215.68 C10H14ClNO2 (S)-beta2-hPhe-OH·HCl >98% 1G 16000 chiralix CX35419-200MG (S)-beta2-homovalineHClsalt (S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride Notavailable 167.63 C6H14ClNO2 (S)-beta2-hVal-OH·HCl >98% 200MG 4800 chiralix CX35419-500MG (S)-beta2-homovalineHClsalt (S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride Notavailable 167.63 C6H14ClNO2 (S)-beta2-hVal-OH·HCl >98% 500MG 9800 chiralix CX35419-1G (S)-beta2-homovalineHClsalt (S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride Notavailable 167.63 C6H14ClNO2 (S)-beta2-hVal-OH·HCl >98% 1G 16000 chiralix CX11583-200MG (R)-beta2-homophenylalanineHClsalt (R)-3-amino-2-benzylpropanoicacidhydrochloride Notavailable 215.68 C10H14ClNO2 (R)-beta2-hPhe-OH·HCl >98% 200MG 4800 chiralix CX11583-500MG (R)-beta2-homophenylalanineHClsalt (R)-3-amino-2-benzylpropanoicacidhydrochloride Notavailable 215.68 C10H14ClNO2 (R)-beta2-hPhe-OH·HCl >98% 500MG 9800 chiralix CX11583-1G (R)-beta2-homophenylalanineHClsalt (R)-3-amino-2-benzylpropanoicacidhydrochloride Notavailable 215.68 C10H14ClNO2 (R)-beta2-hPhe-OH·HCl >98% 1G 16000 chiralix CX92224-200MG (S)-beta2-homoleucineHClsalt (S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride Notavailable 181.66 C7H16ClNO2 (S)-beta2-hLeu-OH·HCl >98% 200MG 4800 chiralix CX92224-500MG (S)-beta2-homoleucineHClsalt (S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride Notavailable 181.66 C7H16ClNO2 (S)-beta2-hLeu-OH·HCl >98% 500MG 9800 chiralix CX92224-1G (S)-beta2-homoleucineHClsalt (S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride Notavailable 181.66 C7H16ClNO2 (S)-beta2-hLeu-OH·HCl >98% 1G 16000 chiralix CX81018-500MG (S)-Fmoc-beta2-homoalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid 203854-58-4 325.36 C19H19NO4 (S)-Fmoc-beta2-hAla-OH >98% 500MG 11200 chiralix CX81018-1G (S)-Fmoc-beta2-homoalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid 203854-58-4 325.36 C19H19NO4 (S)-Fmoc-beta2-hAla-OH >98% 1G 18400 chiralix CX85919-500MG (R)-Fmoc-beta2-homoalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid Notavailable 325.36 C19H19NO4 (R)-Fmoc-beta2-hAla-OH >98% 500MG 11200 chiralix CX85919-1G (R)-Fmoc-beta2-homoalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid Notavailable 325.36 C19H19NO4 (R)-Fmoc-beta2-hAla-OH >98% 1G 18400 chiralix CX98774-500MG (R)-Fmoc-beta2-homoleucine (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid 1018899-99-4 367.44 C22H25NO4 (R)-Fmoc-beta2-hLeu-OH >98% 500MG 11200 chiralix CX98774-1G (R)-Fmoc-beta2-homoleucine (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid 1018899-99-4 367.44 C22H25NO4 (R)-Fmoc-beta2-hLeu-OH >98% 1G 18400 chiralix CX33604-500MG (R)-Fmoc-beta2-homovaline (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid Notavailable 353.41 C21H23NO4 (R)-Fmoc-beta2-hVal-OH >98% 500MG 11200 chiralix CX33604-1G (R)-Fmoc-beta2-homovaline (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid Notavailable 353.41 C21H23NO4 (R)-Fmoc-beta2-hVal-OH >98% 1G 18400 chiralix CX82946-500MG (S)-Fmoc-beta2-homophenylalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid 203854-62-0 401.45 C25H23NO4 (S)-Fmoc-beta2-hPhe-OH >98% 500MG 11200 chiralix CX82946-1G (S)-Fmoc-beta2-homophenylalanine (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid 203854-62-0 401.45 C25H23NO4 (S)-Fmoc-beta2-hPhe-OH >98% 1G 18400 chiralix CX86231-500MG (S)-Fmoc-beta2-homovaline (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid 203854-59-5 353.41 C21H23NO4 (S)-Fmoc-beta2-hVal-OH >98% 500MG 11200 chiralix CX86231-1G (S)-Fmoc-beta2-homovaline (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid 203854-59-5 353.41 C21H23NO4 (S)-Fmoc-beta2-hVal-OH >98% 1G 18400 chiralix CX15046-500MG (R)-Fmoc-beta2-homophenylalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid 828254-16-6 401.45 C25H23NO4 (R)-Fmoc-beta2-hPhe-OH >98% 500MG 11200 chiralix CX15046-1G (R)-Fmoc-beta2-homophenylalanine (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid 828254-16-6 401.45 C25H23NO4 (R)-Fmoc-beta2-hPhe-OH >98% 1G 18400 chiralix CX30199-500MG (S)-Fmoc-beta2-homoleucine (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid 193887-45-5 367.44 C22H25NO4 (S)-Fmoc-beta2-hLeu-OH >98% 500MG 11200 chiralix CX30199-1G (S)-Fmoc-beta2-homoleucine (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid 193887-45-5 367.44 C22H25NO4 (S)-Fmoc-beta2-hLeu-OH >98% 1G 18400 chiralix CX20422-1ML cereulide(50µg/mLinacetonitrile) cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3(50µg/mLinacetonitrile) Notavailable 1153.40 C57H96N6O18 cereulidestocksolution >95% 1ML 5000 chiralix CX87778-1ML 13C6-cereulide(20µg/mLinacetonitrile) cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3(20µg/mLinacetonitrile) Notavailable 1159.36 C5113C6H96N6O18 13C6-cereulidestocksolution >95% 1ML 5000 chiralix CX18112-1G 4-(azidomethyl)benzoicacid 4-(azidomethyl)benzoicacid 79584-03-5 177.16 C8H7N3O2 >98% 1G 3000 chiralix CX18112-5G 4-(azidomethyl)benzoicacid 4-(azidomethyl)benzoicacid 79584-03-5 177.16 C8H7N3O2 >98% 5G 7400 chiralix CX18112-10G 4-(azidomethyl)benzoicacid 4-(azidomethyl)benzoicacid 79584-03-5 177.16 C8H7N3O2 >98% 10G 13200 chiralix CX95981-5G 2,2,2-trichloroethoxysulfonylchloride 2,2,2-trichloroethoxysulfonylchloride 764-09-0 247.91 C2H2Cl4O2S chlorosulfuricacid2,2,2-trichloroethylester >98% 5G 2200 chiralix CX95981-10G 2,2,2-trichloroethoxysulfonylchloride 2,2,2-trichloroethoxysulfonylchloride 764-09-0 247.91 C2H2Cl4O2S chlorosulfuricacid2,2,2-trichloroethylester >98% 10G 4000 chiralix CX95981-25G 2,2,2-trichloroethoxysulfonylchloride 2,2,2-trichloroethoxysulfonylchloride 764-09-0 247.91 C2H2Cl4O2S chlorosulfuricacid2,2,2-trichloroethylester >98% 25G 8400 chiralix CX62483-1G 2-(azidomethyl)benzoicacid 2-(azidomethyl)benzoicacid 289712-57-8 177.16 C8H7N3O2 >98% 1G 4200 chiralix CX62483-2G 2-(azidomethyl)benzoicacid 2-(azidomethyl)benzoicacid 289712-57-8 177.16 C8H7N3O2 >98% 2G 7600 chiralix CX62483-5G 2-(azidomethyl)benzoicacid 2-(azidomethyl)benzoicacid 289712-57-8 177.16 C8H7N3O2 >98% 5G 16000 chiralix CX80461-1G 3-(azidomethyl)benzoicacid 3-(azidomethyl)benzoicacid 905973-32-2 177.16 C8H7N3O2 >98% 1G 4200 chiralix CX80461-2G 3-(azidomethyl)benzoicacid 3-(azidomethyl)benzoicacid 905973-32-2 177.16 C8H7N3O2 >98% 2G 7600 chiralix CX80461-5G 3-(azidomethyl)benzoicacid 3-(azidomethyl)benzoicacid 905973-32-2 177.16 C8H7N3O2 >98% 5G 16000 chiralix CX27597-1G 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazoliumtriflate 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-iumtrifluoromethanesulfonate 1185733-70-3 457.66 C8H10Cl3F3N2O6S2 >98% 1G 2600 chiralix CX27597-5G 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazoliumtriflate 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-iumtrifluoromethanesulfonate 1185733-70-3 457.66 C8H10Cl3F3N2O6S2 >98% 5G 9800 chiralix CX50506-10MG TIS108 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one Notavailable 335.40 C20H21N3O2 >98% 10MG 3600 chiralix CX50506-50MG TIS108 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one Notavailable 335.40 C20H21N3O2 >98% 50MG 13800 chiralix CX50506-100MG TIS108 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one Notavailable 335.40 C20H21N3O2 >98% 100MG 23000 chiralix CX95469-10MG 4-Brdebranone 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one 1332863-94-1 269.09 C11H9BrO3 4BD >98% 10MG 3000 chiralix CX95469-50MG 4-Brdebranone 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one 1332863-94-1 269.09 C11H9BrO3 4BD >98% 50MG 11400 chiralix CX95469-100MG 4-Brdebranone 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one 1332863-94-1 269.09 C11H9BrO3 4BD >98% 100MG 19600 chiralix CX75854-10MG 4-CNdebranone 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one 1332863-97-4 215.20 C12H9NO3 >98% 10MG 3000 chiralix CX75854-50MG 4-CNdebranone 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one 1332863-97-4 215.20 C12H9NO3 >98% 50MG 11400 chiralix CX75854-100MG 4-CNdebranone 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one 1332863-97-4 215.20 C12H9NO3 >98% 100MG 19600 chiralix CX52612-10MG Abamineoxalicacidsalt (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate Notavailable 463.45 C23H26FNO8 >98% 10MG 3000 chiralix CX52612-50MG Abamineoxalicacidsalt (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate Notavailable 463.45 C23H26FNO8 >98% 50MG 11400 chiralix CX52612-100MG Abamineoxalicacidsalt (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate Notavailable 463.45 C23H26FNO8 >98% 100MG 19600 chiralix CX93797-10G Fmoc-D-cyclohexylglycine (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid 198543-96-3 379.45 C23H25NO4 Fmoc-D-Chg-OH >97% 10G 6000 chiralix CX93797-25G Fmoc-D-cyclohexylglycine (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid 198543-96-3 379.45 C23H25NO4 Fmoc-D-Chg-OH >97% 25G 13000 chiralix CX29693-10G Fmoc-L-cyclohexylglycine (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid 161321-36-4 379.45 C23H25NO4 Fmoc-L-Chg-OH >97% 10G 6000 chiralix CX29693-25G Fmoc-L-cyclohexylglycine (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid 161321-36-4 379.45 C23H25NO4 Fmoc-L-Chg-OH >97% 25G 13000 chiralix

产品订购信息如下：

Order No.	Quantity	Price
CX23880-5MG	5 milligrams	6000
CX23880-20MG	20 milligrams	17000
CX23880-100MG	100 milligrams	39000 g